{"id":15243,"date":"2025-07-15T09:02:37","date_gmt":"2025-07-15T06:02:37","guid":{"rendered":"https:\/\/medicalpointinternational.com\/aerzte\/prof-metin-oezgen\/"},"modified":"2026-06-22T09:27:34","modified_gmt":"2026-06-22T06:27:34","slug":"prof-metin-oezgen","status":"publish","type":"page","link":"https:\/\/medicalpointinternational.com\/de\/aerzte\/prof-metin-oezgen\/","title":{"rendered":"Prof. Dr. med. Metin \u00d6zgen"},"content":{"rendered":"<?xml encoding=\"utf-8\" ?><div data-elementor-type=\"wp-page\" data-elementor-id=\"15243\" class=\"elementor elementor-15243 elementor-2615\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5ad8755e e-flex e-con-boxed e-con e-parent\" data-id=\"5ad8755e\" data-element_type=\"container\" data-settings='{\"background_background\":\"slideshow\",\"background_slideshow_gallery\":[{\"id\":1509,\"url\":\"https:\\\/\\\/medicalpointinternational.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/MedicalPoint-International-Hospital-About-Us-Pic.webp\"}],\"background_slideshow_loop\":\"yes\",\"background_slideshow_slide_duration\":5000,\"background_slideshow_slide_transition\":\"fade\",\"background_slideshow_transition_duration\":500}'>\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-2c12cabe e-con-full e-flex e-con e-child\" data-id=\"2c12cabe\" data-element_type=\"container\" data-settings='{\"background_background\":\"classic\"}'>\n\t\t<div class=\"elementor-element elementor-element-40110235 e-con-full e-flex e-con e-child\" data-id=\"40110235\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5110d620 elementor-widget elementor-widget-image\" data-id=\"5110d620\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"572\" src=\"https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2025\/05\/MedicalPoint-International-Hospital-Prof.-Metin-Ozgen-Rheumatology-1024x732.jpg\" class=\"attachment-large size-large wp-image-11007\" alt=\"\" srcset=\"https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2025\/05\/MedicalPoint-International-Hospital-Prof.-Metin-Ozgen-Rheumatology-1024x732.jpg 1024w, https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2025\/05\/MedicalPoint-International-Hospital-Prof.-Metin-Ozgen-Rheumatology-300x214.jpg 300w, https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2025\/05\/MedicalPoint-International-Hospital-Prof.-Metin-Ozgen-Rheumatology-768x549.jpg 768w, https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2025\/05\/MedicalPoint-International-Hospital-Prof.-Metin-Ozgen-Rheumatology-1536x1098.jpg 1536w, https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2025\/05\/MedicalPoint-International-Hospital-Prof.-Metin-Ozgen-Rheumatology.jpg 1652w\" sizes=\"(max-width: 800px) 100vw, 800px\" title=\"\">\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-75038f5f e-con-full e-flex e-con e-child\" data-id=\"75038f5f\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-460bf159 elementor-widget elementor-widget-heading\" data-id=\"460bf159\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Prof. Dr. med. Metin &Ouml;zgen<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-f9919af elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"f9919af\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<i style=\"color:#ffffff\" class=\"fas fa-map-marker-alt\"><\/i> <span>MedicalPoint Izmir Krankenhaus<\/span>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-53fa9bdb elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"53fa9bdb\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<span>Rheumatologie<\/span>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3ec1415b e-con-full e-flex e-con e-child\" data-id=\"3ec1415b\" data-element_type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-159c6fed e-con-full e-flex e-con e-child\" data-id=\"159c6fed\" data-element_type=\"container\" data-settings='{\"background_background\":\"classic\"}'>\n\t\t\t\t<div class=\"elementor-element elementor-element-4101909a elementor-widget elementor-widget-heading\" data-id=\"4101909a\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h3 class=\"elementor-heading-title elementor-size-default\">R&uuml;ckruf anfordern<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7f3a523f ekit_wpForms_container-form-button-full-width elementor-widget-mobile__width-initial elementor-widget elementor-widget-elementskit-wp-forms\" data-id=\"7f3a523f\" data-element_type=\"widget\" data-widget_type=\"elementskit-wp-forms.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"ekit-wid-con ekit_wpForms_container\"><div class=\"wpforms-container wpforms-container-full wpforms-render-modern\" id=\"wpforms-2447\"><form id=\"wpforms-form-2447\" class=\"wpforms-validate wpforms-form wpforms-ajax-form\" data-formid=\"2447\" method=\"post\" enctype=\"multipart\/form-data\" action=\"\/de\/wp-json\/wp\/v2\/pages\/15243\" data-token=\"249ede5e780874120344770376966781\" data-token-time=\"1783987088\"><noscript class=\"wpforms-error-noscript\">Bitte aktivieren Sie JavaScript in Ihrem Browser, um dieses Formular auszuf&uuml;llen.<\/noscript><div class=\"wpforms-hidden\" id=\"wpforms-error-noscript\">Bitte aktivieren Sie JavaScript in Ihrem Browser, um dieses Formular auszuf&uuml;llen.<\/div><div class=\"wpforms-field-container\"><div id=\"wpforms-2447-field_1-container\" class=\"wpforms-field wpforms-field-name\" data-field-id=\"1\"><fieldset><legend class=\"wpforms-field-label wpforms-label-hide\" aria-hidden=\"false\">Name <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/legend><div class=\"wpforms-field-row wpforms-field-large\"><div class=\"wpforms-field-row-block wpforms-first wpforms-one-half\"><input type=\"text\" id=\"wpforms-2447-field_1\" class=\"wpforms-field-name-first wpforms-field-required\" name=\"wpforms[fields][1][first]\" placeholder=\"Name\" aria-errormessage=\"wpforms-2447-field_1-error\" required><label for=\"wpforms-2447-field_1\" class=\"wpforms-field-sublabel after wpforms-sublabel-hide\">Erste<\/label><\/div><div class=\"wpforms-field-row-block wpforms-one-half\"><input type=\"text\" id=\"wpforms-2447-field_1-last\" class=\"wpforms-field-name-last wpforms-field-required\" name=\"wpforms[fields][1][last]\" placeholder=\"Nachname\" aria-errormessage=\"wpforms-2447-field_1-last-error\" required><label for=\"wpforms-2447-field_1-last\" class=\"wpforms-field-sublabel after wpforms-sublabel-hide\">Letzte<\/label><\/div><\/div><\/fieldset><\/div><div id=\"wpforms-2447-field_2-container\" class=\"wpforms-field wpforms-field-phone\" data-field-id=\"2\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-2447-field_2\" aria-hidden=\"false\">Telefon <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"tel\" id=\"wpforms-2447-field_2\" class=\"wpforms-field-large wpforms-field-required wpforms-smart-phone-field\" data-rule-smart-phone-field=\"true\" name=\"wpforms[fields][2]\" placeholder=\"Telefon\" aria-label=\"Telefon\" aria-errormessage=\"wpforms-2447-field_2-error\" required><\/div><div id=\"wpforms-2447-field_4-container\" class=\"wpforms-field wpforms-field-email\" data-field-id=\"4\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-2447-field_4\" aria-hidden=\"false\">E-Mail <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><input type=\"email\" id=\"wpforms-2447-field_4\" class=\"wpforms-field-large wpforms-field-required\" name=\"wpforms[fields][4]\" placeholder=\"E-Mail\" spellcheck=\"false\" aria-errormessage=\"wpforms-2447-field_4-error\" required><\/div><div id=\"wpforms-2447-field_7-container\" class=\"wpforms-field wpforms-field-select wpforms-field-select-style-modern\" data-field-id=\"7\"><label class=\"wpforms-field-label wpforms-label-hide\" for=\"wpforms-2447-field_7\" aria-hidden=\"false\">Land <span class=\"wpforms-required-label\" aria-hidden=\"true\">*<\/span><\/label><select id=\"wpforms-2447-field_7\" class=\"wpforms-field-large wpforms-field-required choicesjs-select\" data-size-class=\"wpforms-field-row wpforms-field-large\" data-search-enabled=\"1\" name=\"wpforms[fields][7]\" required=\"required\"><option value=\"\" class=\"placeholder\" disabled selected>Land<\/option><option value=\"Afghanistan\">Afghanistan<\/option><option value=\"Albanien\">Albanien<\/option><option value=\"Algerien\">Algerien<\/option><option value=\"Andorra\">Andorra<\/option><option value=\"Angola\">Angola<\/option><option value=\"Antigua und Barbuda\">Antigua und Barbuda<\/option><option value=\"Argentinien\">Argentinien<\/option><option value=\"Armenien\">Armenien<\/option><option value=\"Australien\">Australien<\/option><option value=\"&Ouml;sterreich\">&Ouml;sterreich<\/option><option value=\"Aserbaidschan\">Aserbaidschan<\/option><option value=\"Die Bahamas\">Die Bahamas<\/option><option value=\"Bahrain\">Bahrain<\/option><option value=\"Bangladesch\">Bangladesch<\/option><option value=\"Barbados\">Barbados<\/option><option value=\"Wei&szlig;russland\">Wei&szlig;russland<\/option><option value=\"Belgien\">Belgien<\/option><option value=\"Belize\">Belize<\/option><option value=\"Benin\">Benin<\/option><option value=\"Bhutan\">Bhutan<\/option><option value=\"Bolivien\">Bolivien<\/option><option value=\"Bosnien und Herzegowina\">Bosnien und Herzegowina<\/option><option value=\"Botswana\">Botswana<\/option><option value=\"Brasilien\">Brasilien<\/option><option value=\"Brunei\">Brunei<\/option><option value=\"Bulgarien\">Bulgarien<\/option><option value=\"Burkina Faso\">Burkina Faso<\/option><option value=\"Burundi\">Burundi<\/option><option value=\"Cabo Verde\">Cabo Verde<\/option><option value=\"Kambodscha\">Kambodscha<\/option><option value=\"Kamerun\">Kamerun<\/option><option value=\"Kanada\">Kanada<\/option><option value=\"Zentralafrikanische Republik\">Zentralafrikanische Republik<\/option><option value=\"Chad\">Chad<\/option><option value=\"Chile\">Chile<\/option><option value=\"China\">China<\/option><option value=\"Kolumbien\">Kolumbien<\/option><option value=\"Komoren\">Komoren<\/option><option value=\"Kongo, Demokratische Republik\">Kongo, Demokratische Republik<\/option><option value=\"Kongo, Republik der\">Kongo, Republik der<\/option><option value=\"Costa Rica\">Costa Rica<\/option><option value=\"C&ocirc;te d'Ivoire\">C&ocirc;te d'Ivoire<\/option><option value=\"Kroatien\">Kroatien<\/option><option value=\"Kuba\">Kuba<\/option><option value=\"Zypern\">Zypern<\/option><option value=\"Tschechische Republik\">Tschechische Republik<\/option><option value=\"D&auml;nemark\">D&auml;nemark<\/option><option value=\"Dschibuti\">Dschibuti<\/option><option value=\"Dominica\">Dominica<\/option><option value=\"Dominikanische Republik\">Dominikanische Republik<\/option><option value=\"Osttimor (Timor-Leste)\">Osttimor (Timor-Leste)<\/option><option value=\"Ecuador\">Ecuador<\/option><option value=\"&Auml;gypten\">&Auml;gypten<\/option><option value=\"El Salvador\">El Salvador<\/option><option value=\"&Auml;quatorial-Guinea\">&Auml;quatorial-Guinea<\/option><option value=\"Eritrea\">Eritrea<\/option><option value=\"Estland\">Estland<\/option><option value=\"Eswatini\">Eswatini<\/option><option value=\"&Auml;thiopien\">&Auml;thiopien<\/option><option value=\"Fidschi\">Fidschi<\/option><option value=\"Finnland\">Finnland<\/option><option value=\"Frankreich\">Frankreich<\/option><option value=\"Ghana\">Ghana<\/option><option value=\"Griechenland\">Griechenland<\/option><option value=\"Grenada\">Grenada<\/option><option value=\"Guatemala\">Guatemala<\/option><option value=\"Guinea\">Guinea<\/option><option value=\"Guinea-Bissau\">Guinea-Bissau<\/option><option value=\"Guyana\">Guyana<\/option><option value=\"Haiti\">Haiti<\/option><option value=\"Honduras\">Honduras<\/option><option value=\"Ungarn\">Ungarn<\/option><option value=\"Island\">Island<\/option><option value=\"Indien\">Indien<\/option><option value=\"Indonesien\">Indonesien<\/option><option value=\"Iran\">Iran<\/option><option value=\"Irak\">Irak<\/option><option value=\"Irland\">Irland<\/option><option value=\"Israel\">Israel<\/option><option value=\"Italien\">Italien<\/option><option value=\"Jamaika\">Jamaika<\/option><option value=\"Japan\">Japan<\/option><option value=\"Kasachstan\">Kasachstan<\/option><option value=\"Kenia\">Kenia<\/option><option value=\"Kiribati\">Kiribati<\/option><option value=\"Korea, Nord\">Korea, Nord<\/option><option value=\"Korea, S&uuml;d\">Korea, S&uuml;d<\/option><option value=\"Kosovo\">Kosovo<\/option><option value=\"Kuwait\">Kuwait<\/option><option value=\"Kirgisistan\">Kirgisistan<\/option><option value=\"Laos\">Laos<\/option><option value=\"Lettland\">Lettland<\/option><option value=\"Libanon\">Libanon<\/option><option value=\"Lesotho\">Lesotho<\/option><option value=\"Liechtenstein\">Liechtenstein<\/option><option value=\"Litauen\">Litauen<\/option><option value=\"Luxemburg\">Luxemburg<\/option><option value=\"Madagaskar\">Madagaskar<\/option><option value=\"Malawi\">Malawi<\/option><option value=\"Malaysia\">Malaysia<\/option><option value=\"Malediven\">Malediven<\/option><option value=\"Mali\">Mali<\/option><option value=\"Malta\">Malta<\/option><option value=\"Mauritius\">Mauritius<\/option><option value=\"Mexiko\">Mexiko<\/option><option value=\"Mikronesien, F&ouml;derierte Staaten von\">Mikronesien, F&ouml;derierte Staaten von<\/option><option value=\"Moldawien\">Moldawien<\/option><option value=\"Monaco\">Monaco<\/option><option value=\"Mongolei\">Mongolei<\/option><option value=\"Montenegro\">Montenegro<\/option><option value=\"Marokko\">Marokko<\/option><option value=\"Mosambik\">Mosambik<\/option><option value=\"Myanmar (Birma)\">Myanmar (Birma)<\/option><option value=\"Namibia\">Namibia<\/option><option value=\"Nauru\">Nauru<\/option><option value=\"Nepal\">Nepal<\/option><option value=\"Niederlande\">Niederlande<\/option><option value=\"Neuseeland\">Neuseeland<\/option><option value=\"Nicaragua\">Nicaragua<\/option><option value=\"Niger\">Niger<\/option><option value=\"Nigeria\">Nigeria<\/option><option value=\"Nord-Mazedonien\">Nord-Mazedonien<\/option><option value=\"Norwegen\">Norwegen<\/option><option value=\"Oman\">Oman<\/option><option value=\"Pakistan\">Pakistan<\/option><option value=\"Palau\">Palau<\/option><option value=\"Panama\">Panama<\/option><option value=\"Papua-Neuguinea\">Papua-Neuguinea<\/option><option value=\"Paraguay\">Paraguay<\/option><option value=\"Peru\">Peru<\/option><option value=\"Philippinen\">Philippinen<\/option><option value=\"Polen\">Polen<\/option><option value=\"Portugal\">Portugal<\/option><option value=\"Katar\">Katar<\/option><option value=\"Rum&auml;nien\">Rum&auml;nien<\/option><option value=\"Russland\">Russland<\/option><option value=\"Ruanda\">Ruanda<\/option><option value=\"St. Kitts und Nevis\">St. Kitts und Nevis<\/option><option value=\"St. Lucia\">St. Lucia<\/option><option value=\"St. Vincent und die Grenadinen\">St. Vincent und die Grenadinen<\/option><option value=\"Samoa\">Samoa<\/option><option value=\"San Marino\">San Marino<\/option><option value=\"Sao Tome und Principe\">Sao Tome und Principe<\/option><option value=\"Saudi-Arabien\">Saudi-Arabien<\/option><option value=\"Senegal\">Senegal<\/option><option value=\"Serbien\">Serbien<\/option><option value=\"Seychellen\">Seychellen<\/option><option value=\"Sierra Leone\">Sierra Leone<\/option><option value=\"Singapur\">Singapur<\/option><option value=\"Slowakei\">Slowakei<\/option><option value=\"Slowenien\">Slowenien<\/option><option value=\"Salomonen\">Salomonen<\/option><option value=\"Somalia\">Somalia<\/option><option value=\"S&uuml;dafrika\">S&uuml;dafrika<\/option><option value=\"Spanien\">Spanien<\/option><option value=\"Sri Lanka\">Sri Lanka<\/option><option value=\"Sudan\">Sudan<\/option><option value=\"Sudan, S&uuml;d\">Sudan, S&uuml;d<\/option><option value=\"Surinam\">Surinam<\/option><option value=\"Schweden\">Schweden<\/option><option value=\"Schweiz\">Schweiz<\/option><option value=\"Syrien\">Syrien<\/option><option value=\"Taiwan\">Taiwan<\/option><option value=\"Tadschikistan\">Tadschikistan<\/option><option value=\"Tansania\">Tansania<\/option><option value=\"Thailand\">Thailand<\/option><option value=\"Togo\">Togo<\/option><option value=\"Tonga\">Tonga<\/option><option value=\"Trinidad und Tobago\">Trinidad und Tobago<\/option><option value=\"Tunesien\">Tunesien<\/option><option value=\"T&uuml;rkei\">T&uuml;rkei<\/option><option value=\"Turkmenistan\">Turkmenistan<\/option><option value=\"Tuvalu\">Tuvalu<\/option><option value=\"Uganda\">Uganda<\/option><option value=\"Ukraine\">Ukraine<\/option><option value=\"Vereinigte Arabische Emirate\">Vereinigte Arabische Emirate<\/option><option value=\"Vereinigtes K&ouml;nigreich\">Vereinigtes K&ouml;nigreich<\/option><option value=\"Vereinigte Staaten\">Vereinigte Staaten<\/option><option value=\"Uruguay\">Uruguay<\/option><option value=\"Usbekistan\">Usbekistan<\/option><option value=\"Vanuatu\">Vanuatu<\/option><option value=\"Vatikanstadt\">Vatikanstadt<\/option><option value=\"Venezuela\">Venezuela<\/option><option value=\"Vietnam\">Vietnam<\/option><option value=\"Jemen\">Jemen<\/option><option value=\"Sambia\">Sambia<\/option><option value=\"Simbabwe\">Simbabwe<\/option><\/select><\/div><\/div><!-- .wpforms-field-container --><div class=\"wpforms-submit-container\"><input type=\"hidden\" name=\"wpforms[id]\" value=\"2447\"><input type=\"hidden\" name=\"page_title\" value=\"\"><input type=\"hidden\" name=\"page_url\" value=\"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/15243\"><button type=\"submit\" name=\"wpforms[submit]\" id=\"wpforms-submit-2447\" class=\"wpforms-submit\" data-alt-text=\"Senden Sie...\" data-submit-text=\"Einreichen\" aria-live=\"assertive\" value=\"wpforms-submit\">Einreichen<\/button><img decoding=\"async\" src=\"https:\/\/medicalpointinternational.com\/wp-content\/plugins\/wpforms\/assets\/images\/submit-spin.svg\" class=\"wpforms-submit-spinner\" style=\"display: none;\" width=\"26\" height=\"26\" alt=\"Wird geladen\" title=\"\"><\/div><\/form><\/div>  <!-- .wpforms-container --><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-1860779b e-flex e-con-boxed e-con e-parent\" data-id=\"1860779b\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8eaca89 elementor-widget elementor-widget-heading\" data-id=\"8eaca89\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Ausbildung und Fachwissen\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ba66dca elementor-widget elementor-widget-text-editor\" data-id=\"ba66dca\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li>1991 - 1994: &#304;zmir Atat&uuml;rk Gymnasium<br data-start=\"155\" data-end=\"158\"><\/li><li>1994 - 2000: Medizinische Fakult&auml;t der Ondokuz May&#305;s Universit&auml;t<br data-start=\"215\" data-end=\"218\"><\/li><li>2001 - 2006: F&#305;rat University Internal Medicine Specialty Training<br data-start=\"284\" data-end=\"287\"><\/li><li>2008 - 2011: F&#305;rat University Rheumatology Subspecialty Training<br data-start=\"351\" data-end=\"354\"><\/li><li>2012: Au&szlig;erordentlicher Professor - Malatya &#304;n&ouml;n&uuml; Universit&auml;t<br data-start=\"406\" data-end=\"409\"><\/li><li>2020: Professor - Ondokuz May&#305;s Universit&auml;t\t\t\t\t\t\t\t\t<\/li><\/ul><\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-9c9270e elementor-widget elementor-widget-heading\" data-id=\"9c9270e\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Krankheiten<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-1a2f8c4 elementor-widget elementor-widget-text-editor\" data-id=\"1a2f8c4\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul data-start=\"470\" data-end=\"728\"><li data-start=\"470\" data-end=\"508\"><p data-start=\"472\" data-end=\"508\">Famili&auml;res Mittelmeerfieber (FMF)<\/p><\/li><li data-start=\"509\" data-end=\"535\"><p data-start=\"511\" data-end=\"535\">Spondylitis ankylosans<\/p><\/li><li data-start=\"536\" data-end=\"556\"><p data-start=\"538\" data-end=\"556\">Beh&ccedil;et-Krankheit<\/p><\/li><li data-start=\"557\" data-end=\"583\"><p data-start=\"559\" data-end=\"583\">Granulomat&ouml;se Mastitis<\/p><\/li><li data-start=\"584\" data-end=\"592\"><p data-start=\"586\" data-end=\"592\">Gicht<\/p><\/li><li data-start=\"593\" data-end=\"616\"><p data-start=\"595\" data-end=\"616\">Psoriatische Arthritis<\/p><\/li><li data-start=\"617\" data-end=\"641\"><p data-start=\"619\" data-end=\"641\">Rheumatoide Arthritis<\/p><\/li><li data-start=\"642\" data-end=\"657\"><p data-start=\"644\" data-end=\"657\">Sarkoidose<\/p><\/li><li data-start=\"658\" data-end=\"690\"><p data-start=\"660\" data-end=\"690\">Systemischer Lupus Erythematosus<\/p><\/li><li data-start=\"691\" data-end=\"713\"><p data-start=\"693\" data-end=\"713\">Sj&ouml;gren-Syndrom<\/p><\/li><li data-start=\"714\" data-end=\"728\"><p data-start=\"716\" data-end=\"728\">Vaskulitis<\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e2f6332 elementor-widget elementor-widget-heading\" data-id=\"e2f6332\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Behandlungsmethoden<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a7925a9 elementor-widget elementor-widget-text-editor\" data-id=\"a7925a9\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul data-start=\"470\" data-end=\"728\">\n\n \t<li data-start=\"754\" data-end=\"776\">\n<p data-start=\"756\" data-end=\"776\">Infusionstherapien<\/p>\n<\/li>\n \t<li data-start=\"777\" data-end=\"823\">\n<p data-start=\"779\" data-end=\"823\">Diagnostische muskuloskelettale Ultraschalluntersuchung<\/p>\n<\/li>\n \t<li data-start=\"824\" data-end=\"849\">\n<p data-start=\"826\" data-end=\"849\">Speicheldr&uuml;sen-Biopsie<\/p>\n<\/li>\n \t<li data-start=\"850\" data-end=\"906\">\n<p data-start=\"852\" data-end=\"906\">Ultraschallgesteuerte Injektion in wichtige Gelenkbereiche<\/p>\n<\/li>\n<\/ul>\n\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-aba06e5 elementor-widget elementor-widget-heading\" data-id=\"aba06e5\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Erleben Sie<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b0908a5 elementor-widget elementor-widget-text-editor\" data-id=\"b0908a5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><p data-start=\"756\" data-end=\"776\"><\/p><li>2000 - 2001: Sozialversicherungsambulanz, Sungurlu, &Ccedil;orum<br data-start=\"981\" data-end=\"984\"><\/li><li>2001 - 2006: Forschungsassistent, Abteilung f&uuml;r Innere Medizin, F&#305;rat Universit&auml;t<br data-start=\"1066\" data-end=\"1069\"><\/li><li>2008 - 2011: Forschungsassistent, Abteilung f&uuml;r Rheumatologie, F&#305;rat Universit&auml;t<br data-start=\"1146\" data-end=\"1149\"><\/li><li>2012 - 2014: Au&szlig;erordentlicher Professor, &#304;n&ouml;n&uuml; Universit&auml;t, Malatya<br data-start=\"1208\" data-end=\"1211\"><\/li><li>2014 - 2019: Au&szlig;erordentlicher Professor, Ondokuz May&#305;s Universit&auml;t<br data-start=\"1269\" data-end=\"1272\"><\/li><li>2020 - 2024: Professor, Ondokuz May&#305;s Universit&auml;t\t\t\t\t\t\t\t\t<\/li><\/ul><\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a112d64 elementor-widget elementor-widget-heading\" data-id=\"a112d64\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Berufliche Mitgliedschaften<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a6ef3db elementor-widget elementor-widget-text-editor\" data-id=\"a6ef3db\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul data-start=\"1355\" data-end=\"1416\"><li data-start=\"1355\" data-end=\"1390\"><p data-start=\"1357\" data-end=\"1390\">T&uuml;rkische Gesellschaft f&uuml;r Rheumatologie<\/p><\/li><li data-start=\"1391\" data-end=\"1416\"><p data-start=\"1393\" data-end=\"1416\">&#304;zmir Medizinische Kammer<\/p><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-746a349 elementor-widget elementor-widget-heading\" data-id=\"746a349\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Forschung Publikationen<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-4d9dee4e elementor-widget elementor-widget-text-editor\" data-id=\"4d9dee4e\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"1447\" data-end=\"1455\"><em data-start=\"1447\" data-end=\"1453\">2024<\/em><\/p>\n\n<ul data-start=\"1456\" data-end=\"1880\">\n \t<li data-start=\"1456\" data-end=\"1666\">\n<p data-start=\"1458\" data-end=\"1666\">Guluzade E, G&uuml;zel B, Yalcin Kehribar D, Okuyucu M, &Ouml;zgen M, Avc&#305; B. The Role of Tenascin-C in the Physiopathology of Familial Mediterranean Fever. Cureus. 2024 Jul 8;16(7):e64067. doi: 10.7759\/cureus.64067.   <\/p>\n<\/li>\n \t<li data-start=\"1667\" data-end=\"1880\">\n<p data-start=\"1669\" data-end=\"1880\">Kaplan H, Yalcin Kehribar D, Okuyucu M, Ozgen M. Eine Untersuchung der Beziehung zwischen dem Morbus Beh&ccedil;et und Tenascin-C. Arch Rheumatol. 2024 Jan 15;39(1):107-114. doi: 10.46497\/ArchRheumatol.2024.10163. <\/p>\n<\/li>\n<\/ul>\n<p data-start=\"1882\" data-end=\"1890\"><em data-start=\"1882\" data-end=\"1888\">2023<\/em><\/p>\n\n<ul data-start=\"1891\" data-end=\"2765\">\n \t<li data-start=\"1891\" data-end=\"2307\">\n<p data-start=\"1893\" data-end=\"2307\">&#304;nan&ccedil; GN, Terzio&#287;lu ME, Karabulut Y, Y&#305;lmaz Z, Tarhan EF, Enecik ME, &#350;ahin A, K&uuml;&ccedil;&uuml;k A, Ayan A, &Ouml;zgen M, Karasu U, Yolba&#351; S. Eine nationale, multizentrische, retrospektive Studie zur Bewertung der Verweildauer und Wirksamkeit der Tocilizumab-Behandlung bei Patienten mit aktiver rheumatoider Arthritis, die unzureichend auf csDMARDs und\/oder TNF-Hemmer angesprochen haben. Turk J Med Sci. 2023 Jun;53(3):731-743. doi: 10.55730\/1300-0144.5636 <\/p>\n<\/li>\n \t<li data-start=\"2308\" data-end=\"2765\">\n<p data-start=\"2310\" data-end=\"2765\">Temiz Karadag D, Yalcinkaya Y, Akdogan A, Avanoglu A, Bes C, Birlik AM, Cefle A, Erdogan M, Hatemi G, Icacan OC, Inanc M, Inanc N, Koca SS, Kucuksahin O, Ozgen M, Sari A, Sahin A, Senel S, Tufan A, Ugurlu S, Yargucu Zihni F, Yolbas S, Hamuryudan V. Behandlung von digitalen Geschw&uuml;ren im Zusammenhang mit systemischer Sklerose: Empfehlungen der T&uuml;rkischen Gesellschaft f&uuml;r Rheumatologie. Clin Exp Rheumatol. 2023 Aug;41(8):1679-1687. doi: 10.55563\/clinexprheumatol\/ce13vk (Q2)   <\/p>\n<\/li>\n<\/ul>\n<p data-start=\"2767\" data-end=\"2775\"><em data-start=\"2767\" data-end=\"2773\">2022<\/em><\/p>\n\n<ul data-start=\"2776\" data-end=\"4256\">\n \t<li data-start=\"2776\" data-end=\"3069\">\n<p data-start=\"2778\" data-end=\"3069\">&Ccedil;oksevim M, &Ccedil;erik &#304;B, Yener&ccedil;a&#287; M, Kocasar&#305; AO, Yavuzbilge G, Polat M, Meri&ccedil; M, &Ouml;zgen M. Assessment of pulmonary arterial stiffness in patients with systemic sclerosis without overt pulmonary hypertension. Int J Cardiovasc Imaging. 2022 Oct;38(10):2191-2197. doi: 10.1007\/s10554-022-02625-9   <\/p>\n<\/li>\n \t<li data-start=\"3070\" data-end=\"3311\">\n<p data-start=\"3072\" data-end=\"3311\">Kehribar DY, Emmungil H, T&uuml;rkmen NB, &Ccedil;ift&ccedil;i O, Salva E, &Ouml;zgen M. Der EGFR-Blocker Lapatinib hemmt die Synthese von Matrix-Metalloproteinasen in synovialen Fibroblasten. Turk J Med Sci. 2022 Aug;52(4):1355-1361. doi: 10.55730\/1300-0144.5442 <\/p>\n<\/li>\n \t<li data-start=\"3312\" data-end=\"3545\">\n<p data-start=\"3314\" data-end=\"3545\">Okuyucu M, Yalcin Kehribar D, &Ccedil;apraz M, &Ccedil;apraz A, Arslan M, &Ccedil;elik ZB, Usta B, Birinci A, Ozgen M. The Relationship Between COVID-19 Disease Severity and Zonulin Levels. Cureus. 2022 Aug 22;14(8):e28255. doi: 10.7759\/cureus.28255.   <\/p>\n<\/li>\n \t<li data-start=\"3546\" data-end=\"3742\">\n<p data-start=\"3548\" data-end=\"3742\">Okuyucu M, Ozdemir AZ, Yalcin Kehribar D, Ozgen M. Ovarielle Reserve und Ultraschalluntersuchung des Beckens bei famili&auml;rem Mittelmeerfieber. Cureus. 2022 Aug 15;14(8):e28027. doi: 10.7759\/cureus.28027   <\/p>\n<\/li>\n \t<li data-start=\"3743\" data-end=\"4256\">\n<p data-start=\"3745\" data-end=\"4256\">Akyol L, Toz B, Bay&#305;nd&#305;r &Ouml;, Zengin O, Cansu D, Yi&#287;it M, &Ccedil;etin GY, Omma A, Erden A, K&uuml;&ccedil;&uuml;k&#351;ahin O, Altuner M&#350;, &Ccedil;orba B, &Uuml;nal AU, K&uuml;&ccedil;&uuml;k H, K&uuml;&ccedil;&uuml;k A, Balkarli A, G&ouml;n&uuml;ll&uuml; E, Tufan AN, Bak&#305;rc&#305; S, &Ouml;ner SY, Balc&#305; MA, Kobak &#350;, Yaz&#305;c&#305; A, &Ouml;zgen M, &#350;ahin A, Koca SS, Erer B, G&uuml;l A, Aksu K, Keser G, Onat AM, K&#305;sac&#305;k B, Ka&#351;ifo&#287;lu T, &Ccedil;efle A, Kalyoncu U, Sayarl&#305;o&#287;lu M. Budd-Chiari-Syndrom bei Morbus Beh&ccedil;et: eine retrospektive multizentrische Studie. Clin Rheumatol. 2022 Jan;41(1):177-186. doi: 10.1007\/s10067-021-05878-2. (Q2)    <\/p>\n<\/li>\n<\/ul>\n<p data-start=\"4258\" data-end=\"4266\"><em data-start=\"4258\" data-end=\"4264\">2021<\/em><\/p>\n\n<ul data-start=\"4267\" data-end=\"5217\">\n \t<li data-start=\"4267\" data-end=\"4470\">\n<p data-start=\"4269\" data-end=\"4470\">Yalcin Kehribar D, Gunaydin S, Ozgen M. Infliximab-Therapie bei parenchymat&ouml;sem Neuro-Beh&ccedil;et-Syndrom: Eine Erfahrung aus einem einzigen Zentrum. Int J Rheum Dis. 2021 Oct;24(10):1302-1307. doi: 10.1111\/1756-185X.14209.   <\/p>\n<\/li>\n \t<li data-start=\"4471\" data-end=\"4788\">\n<p data-start=\"4473\" data-end=\"4788\">Yal&ccedil;&#305;n Kehribar D, &Ouml;zgen M, Yolba&#351; S, Y&#305;ld&#305;r&#305;m A, &Ouml;nalan Etem E, &Ccedil;ift&ccedil;i O, &Ouml;zercan &#304;H, Koca SS. Die Hemmung der Src-Kinase unterdr&uuml;ckt die Produktion von Matrix-Metalloproteinasen in synovialen Fibroblasten und hemmt MAPK- und STATs-Signalwege.  Turk J Med Sci. 2021 Aug 30;51(4):2142-2149. doi: 10.3906\/sag-2008-274. <\/p>\n<\/li>\n \t<li data-start=\"4789\" data-end=\"5048\">\n<p data-start=\"4791\" data-end=\"5048\">Der Rezeptor f&uuml;r fortgeschrittene Glykierungsendprodukte (RAGE) bei COVID-19. Yalcin Kehribar D, Cihangiroglu M, Sehmen E, Avci B, Capraz A, Yildirim Bilgin A, Gunaydin C, Ozgen M. Biomarkers. 2021 Mar;26(2):114-118. doi: 10.1080\/1354750X.2020.1861099. (Q2)<\/p>\n<\/li>\n \t<li data-start=\"5049\" data-end=\"5217\">\n<p data-start=\"5051\" data-end=\"5217\">K&#305;r S, &Ouml;zgen M, Zontul S. Morbus Still im Erwachsenenalter und Behandlungsergebnisse mit Tocilizumab. Int J Clin Pract. 2021 Mar;75(3):e13936. doi: 10.1111\/ijcp.13936. (Q2)  <\/p>\n<\/li>\n<\/ul>\n<p data-start=\"5219\" data-end=\"5227\"><em data-start=\"5219\" data-end=\"5225\">2020<\/em><\/p>\n\n<ul data-start=\"5228\" data-end=\"7166\">\n \t<li data-start=\"5228\" data-end=\"5436\">\n<p data-start=\"5230\" data-end=\"5436\">Duran TI, Kehribar DY, Ozgen M. Adult-onset Still&rsquo;s Disease Detected in Ankylosing Spondylitis Patient using Adalimumab. J Coll Physicians Surg Pak. 2020 Dec;30(12):1364. doi: 10.29271\/jcpsp.2020.12.1364.   <\/p>\n<\/li>\n \t<li data-start=\"5437\" data-end=\"5683\">\n<p data-start=\"5439\" data-end=\"5683\">Yal&ccedil;&#305;n Kehribar D, Cihangiro&#287;lu M, Sehmen E, Avc&#305; B, &Ccedil;apraz M, Boran M, G&uuml;naydin C, &Ouml;zgen M. The assessment of the serum levels of TWEAK and prostaglandin F2&alpha; in COVID-19. Turk J Med Sci. 2020 Dec 17;50(8):1786-1791. doi: 10.3906\/sag-2006-96. <\/p>\n<\/li>\n \t<li data-start=\"5684\" data-end=\"5885\">\n<p data-start=\"5686\" data-end=\"5885\">Kehribar DY, Duran TI, Polat AK, Ozgen M. Effectiveness of Methotrexate in Idiopathic Granulomatous Mastitis Treatment. Am J Med Sci. 2020 Nov;360(5):560-565. doi: 10.1016\/j.amjms.2020.05.029. (Q2)    <\/p>\n<\/li>\n \t<li data-start=\"5886\" data-end=\"6066\">\n<p data-start=\"5888\" data-end=\"6066\">Kehribar DY, Ozgen M. Infliximab-Behandlung bei refrakt&auml;rem vaskul&auml;rem Morbus Beh&ccedil;et: Eine Erfahrung aus einem einzigen Zentrum. Vascular. 2020 Dec;28(6):829-833. doi: 10.1177\/1708538120927701.<\/p>\n<\/li>\n \t<li data-start=\"6067\" data-end=\"6355\">\n<p data-start=\"6069\" data-end=\"6355\">Karatas A, Dagli AF, Orhan C, Gencoglu H, Ozgen M, Sahin N, Sahin K, Koca SS. Epigallocatechin-3-Gallat mildert Arthritis durch Regulierung von Nrf2, HO-1 und Zytokinspiegeln in einem experimentellen Arthritis-Modell. Biotechnol Appl Biochem. 2020 May;67(3):317-322. doi: 10.1002\/bab.1860. (Q2)     <\/p>\n<\/li>\n \t<li data-start=\"6356\" data-end=\"6538\">\n<p data-start=\"6358\" data-end=\"6538\">Kehribar DY, &Ouml;zgen M. Die Bedeutung des Mittelmeerfieber-Gens beim famili&auml;ren Mittelmeerfieber. Eur J Rheumatol. 2020 Jul 21;7(4):173-6. doi: 10.5152\/eurjrheum.2020.20107. (Q2)  <\/p>\n<\/li>\n \t<li data-start=\"6539\" data-end=\"6763\">\n<p data-start=\"6541\" data-end=\"6763\">Kehribar DY, &Ouml;zgen M. Wirksamkeit der Anti-Interleukin-1-Behandlung bei Colchicin-resistenter Arthritis bei Patienten mit famili&auml;rem Mittelmeerfieber. Eur J Rheumatol. 2021 Jan;8(1):16-19. doi: 10.5152\/eurjrheum.2020.20126 (Q2) <\/p>\n<\/li>\n \t<li data-start=\"6764\" data-end=\"6971\">\n<p data-start=\"6766\" data-end=\"6971\">G&uuml;rb&uuml;z C, Yal&ccedil;&#305;n Kehribar D, &Ouml;zgen M. Klinische Manifestationen des Beh&ccedil;et-Syndroms: Eine Single-Center-Kohorte von 777 Patienten. Eur J Rheumatol. 2021 Oct;8(4):211-216. doi: 10.5152\/eurjrheum.2020.21199. (Q2)  <\/p>\n<\/li>\n \t<li data-start=\"6972\" data-end=\"7166\">\n<p data-start=\"6974\" data-end=\"7166\">Duran T&#304;, &Ouml;zgen M. Zwei F&auml;lle von Kalzium-Pyrophosphat-Ablagerungen (CPPD) mit Spondylodiszitis. Eur J Rheumatol. 2020 Apr;7(2):84-87. doi: 10.5152\/eurjrheum.2020.19180. (Q2)  <\/p>\n<\/li>\n<\/ul>\n<p data-start=\"7168\" data-end=\"7212\"><strong data-start=\"7168\" data-end=\"7210\">W&auml;hrend des Verfahrens f&uuml;r eine au&szlig;erordentliche Professur<\/strong><\/p>\n\n<ul data-start=\"7213\" data-end=\"11092\" data-is-last-node=\"\" data-is-only-node=\"\">\n \t<li data-start=\"7213\" data-end=\"7468\">\n<p data-start=\"7215\" data-end=\"7468\">G&uuml;l FC, Turgut B, Da&#287;l&#305; F, Ilhan N, &Ouml;zgen M. The comparison of the impact of ghrelin and tacrolimus on vitreous cytokine levels in an experimental uveitis model. Graefes Arch Clin Exp Ophthalmol. 2013 Apr;251(4):1235-41. doi: 10.1007\/s00417-013-2259-x   <\/p>\n<\/li>\n \t<li data-start=\"7469\" data-end=\"7657\">\n<p data-start=\"7471\" data-end=\"7657\">Turgut B, G&uuml;l FC, Da&#287;li F, Ilhan N, &Ouml;zgen M. Impact of ghrelin on vitreous cytokine levels in an experimental uveitis model. Drug Des Devel Ther. 2013;7:19-24. doi: 10.2147\/DDDT.S39453   <\/p>\n<\/li>\n \t<li data-start=\"7658\" data-end=\"7849\">\n<p data-start=\"7660\" data-end=\"7849\">Koca SS, Akbas F, Ozgen M, Yolbas S, Ilhan N, Gundogdu B, Isik A. Serum-Galektin-3-Spiegel bei systemischer Sklerose. Clin Rheumatol. 2014 Feb;33(2):215-20. doi: 100.1007\/s10067-013-2346-8 (Q2)   <\/p>\n<\/li>\n \t<li data-start=\"7850\" data-end=\"8089\">\n<p data-start=\"7852\" data-end=\"8089\">Koca SS, Kara M, &Ouml;zgen M, Dagli MN, Gozel N, Yolbas S, Gundogdu B, Kargun K, Isik A. Das rs3768777-G-Allel des ITGAV-Gens steht im Zusammenhang mit rheumatoider Arthritis. Rheumatol Int. Mai 2014; 34(5):693&ndash;8. doi: 10.1007\/s00296-013-2925-7 (Q2)<\/p>\n<\/li>\n \t<li data-start=\"8090\" data-end=\"8292\">\n<p data-start=\"8092\" data-end=\"8292\">Koca SS, Kara M, Deniz F, Ozgen M, Demir CF, Ilhan N, Isik A. Serum-IL-33-Spiegel und IL-33-Gen-Polymorphismen bei Morbus Beh&ccedil;et. Rheumatol Int. 2015 Mar;35(3):471-7. doi: 10.1007\/s00296-014-3111-2. <\/p>\n<\/li>\n \t<li data-start=\"8293\" data-end=\"8497\">\n<p data-start=\"8295\" data-end=\"8497\">Karatas A, Koca SS, Ozgen M, Dagli AF, Erman F, Sahin N, Sahin K, Isik A. Pemetrexed bessert die experimentelle Arthritis bei Ratten. Entz&uuml;ndungen. 2015 Feb;38(1):9-15. doi: 10.1007\/s10753-014-0002-3. (Q2)  <\/p>\n<\/li>\n \t<li data-start=\"8498\" data-end=\"8705\">\n<p data-start=\"8500\" data-end=\"8705\">Ozgen M, Koca SS, Karatas A, Dagli AF, Erman F, Gundogdu B, Sahin K, Isik A. Lapatinib bessert die experimentelle Arthritis bei Ratten. Entz&uuml;ndungen. 2015 Feb;38(1):252-9. doi: 10.1007\/s10753-014-0028-6. (Q2)  <\/p>\n<\/li>\n \t<li data-start=\"8706\" data-end=\"8917\">\n<p data-start=\"8708\" data-end=\"8917\">Akyol L, Aslan K, &Ouml;zgen M, Sayarlioglu M. Bilaterale Sakroiliitis und Uveitis Komorbidit&auml;t: Brucellose? Spondylitis ankylosans? BMJ Case Rep. 2015 Sep 22;2015. pii: bcr2015211461. doi: 10.1136\/bcr-2015-211461<\/p>\n<\/li>\n \t<li data-start=\"8918\" data-end=\"9228\">\n<p data-start=\"8920\" data-end=\"9228\">Oztuzcu S, Onat AM, Pehlivan Y, Alibaz-Oner F, Donmez S, Cetin GY, Yolbas S, Bozgeyik I, Yilmaz N, Ozgen M, Cagatay Y, Kisacik B, Koca SS, Pamuk ON, Sayarlioglu M, Direskeneli H, Demiryurek AT. Assoziation von TRPM-Kanal-Gen-Polymorphismen mit systemischer Sklerose. In Vivo. 2015 Nov-Dec;29(6):763-70. (Q2)    <\/p>\n<\/li>\n \t<li data-start=\"9229\" data-end=\"9420\">\n<p data-start=\"9231\" data-end=\"9420\">Akyol L, Aslan K, &Ouml;zgen M, Sayarl&#305;o&#287;lu M. A rare comorbidity: neurosarcoidosis and cutaneous sarcoidosis. BMJ Case Rep. 2015 Nov 17;2015. pii: bcr2015211439. doi: 10.1136\/bcr-2015-211439.<\/p>\n<\/li>\n \t<li data-start=\"9421\" data-end=\"9779\">\n<p data-start=\"9423\" data-end=\"9779\">Pehlivan Y, Yolbas S, Cetin GY, Alibaz-Oner F, Cagatay Y, Yilmaz N, Oztuzcu S, Donmez S, Ozgen M, Koca SS, Pamuk ON, Sayarl&#305;o&#287;lu M, Kisacik B, Direskeneli H, Demiryurek AT, Onat AM. Untersuchung des Zusammenhangs zwischen Rho\/Rho-Kinase-Gen-Polymorphismen und systemischer Sklerose.  Rheumatol Int. 2016 Mar;36(3):421-7. doi: 10.1007\/s00296-015-3400-4. (Q1)  <\/p>\n<\/li>\n \t<li data-start=\"9780\" data-end=\"10074\">\n<p data-start=\"9782\" data-end=\"10074\">Koca SS, Pehlivan Y, Kara M, Alibaz-Oner F, Oztuzcu S, Yilmaz N, Cetin GY, Kisacik B, Ozgen M, Pamuk ON, Direskeneli H, Sayarlioglu M, Onat AM. Das IL-33-Gen steht im Zusammenhang mit einer erh&ouml;hten Anf&auml;lligkeit f&uuml;r systemische Sklerose.  Rheumatol Int. 2016 Apr;36(4):579-84. doi: 10.1007\/s00296-015-3417-8. <\/p>\n<\/li>\n \t<li data-start=\"10075\" data-end=\"10296\">\n<p data-start=\"10077\" data-end=\"10296\">Koca SS, Ozgen M, Dagli AF, Gozel N, Ozercan IH, Isik A. Die sch&uuml;tzende Wirkung von Bevacizumab bei Bleomycin-induzierter experimenteller Sklerodermie. Adv Clin Exp Med. 2016 Mar-Apr;25(2):249-53. doi: 10.17219\/acem\/32484. (Q1)   <\/p>\n<\/li>\n \t<li data-start=\"10297\" data-end=\"10530\">\n<p data-start=\"10299\" data-end=\"10530\">Da&#287;li AF, Karata&#351; A, Orhan C, Tuzcu M, &Ouml;zgen M, &#350;ahin K, Koca SS. Entz&uuml;ndungshemmende und antioxidative Wirkungen von Gemcitabin im Kollagen-induzierten Arthritis-Modell.  Turk J Med Sci. 2017 Jun 12;47(3):1037-1044. doi: 10.3906\/sag-1606-80. <\/p>\n<\/li>\n \t<li data-start=\"10531\" data-end=\"10780\">\n<p data-start=\"10533\" data-end=\"10780\">Koca SS, Kara M, &Ouml;zgen M, Dayanan R, Demir CF, Aksoy K, &#304;lhan N, D&ouml;nder E, I&#351;&#305;k A. Die geringe Pr&auml;valenz von Adipositas bei der Beh&ccedil;et-Krankheit steht im Zusammenhang mit einem hohen Obestatin-Spiegel. Eur J Rheumatol. Juni 2017; 4(2):113&ndash;117. doi: 10.5152\/eurjrheum.2017.160095.<\/p>\n<\/li>\n<\/ul>\n<div>\n<p data-start=\"81\" data-end=\"121\"><strong data-start=\"81\" data-end=\"121\">Internationale, von Experten begutachtete Artikel<\/strong><\/p>\n<ul><li><p data-start=\"123\" data-end=\"370\">Koca SS, Kara M, &Ouml;zgen M, Dayanan R, Demir CF, Aksoy K, &#304;lhan N, D&ouml;nder E, I&#351;&#305;k A. Die geringe Pr&auml;valenz von Adipositas bei Morbus Beh&ccedil;et steht im Zusammenhang mit einem hohen Obestatin-Spiegel. <em data-start=\"293\" data-end=\"311\">Eur J Rheumatol.<\/em> Juni 2017; 4(2):113&ndash;117. doi: 10.5152\/eurjrheum.2017.160095.<\/p>\n<\/li><li><p data-start=\"372\" data-end=\"943\">Akar S, Cetin P, Kalyoncu U, Karadag O, Sari I, C&#305;nar M, Yilmaz S, Onat AM, Kisacik B, Erden A, Balkarli A, Kucuksahin O, Oner SY, Senel S, Tufan A, Direskeneli H, Oksuz F, Pehlivan Y, Bayindir O, Keser G, Aksu K, Omma A, Kasifoglu T, Unal AU, Yildiz F, Balci MA, Yavuz S, Erten S, Ozgen M, Sayarl&#305;oglu M, Dogru A, Yildirim G, Oner FA, Tezcan ME, Pamuk ON, Onen F. Landesweite Erfahrungen mit dem Off-Label-Einsatz einer Interleukin-1-Targeting-Behandlung bei Patienten mit famili&auml;rem Mittelmeerfieber.  <em data-start=\"857\" data-end=\"888\">Arthritis Care Res (Hoboken).<\/em>  Juli 2018; 70(7):1090&ndash;1094. doi: 10.1002\/acr.23446. (Q1) <\/p>\n<\/li><li><p data-start=\"945\" data-end=\"1178\">Yolba&#351; S., Y&#305;ld&#305;r&#305;m A., D&uuml;zenci D., G&uuml;ndo&#287;du B., &Ouml;zgen M., Koca S. S. Schlafqualit&auml;t, Schlafhaltungen und Schlafzubeh&ouml;r bei Patienten mit ankylosierender Spondylitis.  <em data-start=\"1106\" data-end=\"1123\">Turk J Med Sci.<\/em>  23. August 2017; 47(4):1198&ndash;1205. doi: 10.3906\/sag-1605-62.<\/p>\n<\/li><li><p data-start=\"1180\" data-end=\"1389\">Kir S, Akyol L, &Ouml;zgen M, Pinar G&uuml;nbey H, Sayarlio&#287;lu M. Ptosis and Mass Like Lesions in Beh&ccedil;et&rsquo;s Disease: Eine seltene Pr&auml;sentation.  <em data-start=\"1307\" data-end=\"1324\">Arch Rheumatol.<\/em>  16. Oktober 2017; 33(2):221&ndash;224. doi: 10.5606\/ArchRheumatol.2018.6515.<\/p>\n<\/li><li><p data-start=\"1391\" data-end=\"1570\">Koca SS, &Ouml;zgen M, I&#351;&#305;k B, Da&#287;l&#305; MN, &Uuml;st&uuml;nda&#287; B, I&#351;&#305;k A. Serum-Salusin-&alpha;-Spiegel bei systemischem Lupus erythematosus und systemischer Sklerose.  <em data-start=\"1526\" data-end=\"1544\">Eur J Rheumatol.<\/em>  M&auml;rz 2014; 1(1): 14&ndash;17. (Q2)<\/p>\n<\/li><li><p data-start=\"1572\" data-end=\"1790\">Akyol L, &Ouml;nem S, &Ouml;zgen M, Sayarl&#305;o&#287;lu M. Ethylendiamintetraessigs&auml;ure-abh&auml;ngige Pseudothrombozytopenie bei einem Patienten mit systemischem Lupus erythematosus und Lupusnephritis.  <em data-start=\"1746\" data-end=\"1764\">Eur J Rheumatol.<\/em>  M&auml;rz 2016; 3(1): 36&ndash;37. (Q2)<\/p>\n<\/li><li><p data-start=\"1792\" data-end=\"1934\">Akyol L, &Ouml;nem S, &Ouml;zgen M, Sayarl&#305;o&#287;lu M. Das Sj&ouml;gren-Syndrom nach Silikon-Brustimplantation.  <em data-start=\"1888\" data-end=\"1906\">Eur J Rheumatol.<\/em>  Dez. 2015; 2(4): 165&ndash;166. (Q2)<\/p>\n<\/li><li><p data-start=\"1936\" data-end=\"2128\">Akyol L, G&uuml;nbey E, Karl&#305; R, &Ouml;nem S, &Ouml;zgen M, Sayarl&#305;o&#287;lu M. Bewertung der Geruchsfunktion bei Morbus Beh&ccedil;et.  <em data-start=\"2050\" data-end=\"2068\">Eur J Rheumatol.<\/em>  Dezember 2016; 3(4):153&ndash;156. doi: 10.5152\/eurjrheum.2016.017 (Q2)<\/p>\n<\/li><li><p data-start=\"2130\" data-end=\"2377\">I&#351;&#305;kl&#305; G, Akyol L, U&ccedil;ak SS, Aslan K, &Ouml;zgen M, Sayarl&#305;o&#287;lu M. Heterotopische Ossifikation (Myositis ossificans progressiva): Ein Zustand, der die rheumatische Erkrankung beeintr&auml;chtigt.  <em data-start=\"2299\" data-end=\"2317\">Eur J Rheumatol.<\/em>  M&auml;rz 2017; 4(1): 79&ndash;80. doi: 10.5152\/eurjrheum.2016.15061 (Q2)<\/p>\n<p data-start=\"2384\" data-end=\"2415\"><strong data-start=\"2384\" data-end=\"2415\">Pre-Associate-Professur<\/strong><\/p>\n<\/li><li><p data-start=\"2417\" data-end=\"2560\">S. Koca, M. &Ouml;zgen, S. Ayd&#305;n, S. Dag, B. Evren, A. Isik. Ghrelin- und Obestatin-Spiegel bei rheumatoider Arthritis.  <em data-start=\"2521\" data-end=\"2536\">Entz&uuml;ndungen.<\/em>  2008;31(5):329&ndash;35. (Q2)<\/p>\n<\/li><li><p data-start=\"2562\" data-end=\"2787\">Dogukan, E. Ilkay, O. K. Poyrazoglu, A. I. Gunal, M. Ozgen, M. Pekdemir. Vorhofflimmern infolge einer oralen Methylprednisolon-Therapie bei einem Patienten mit membranoproliferativer Glomerulonephritis.  <em data-start=\"2739\" data-end=\"2770\">Acta Medica (Hradec Kralove).<\/em>  2008;51(1):63-4.<\/p>\n<\/li><li><p data-start=\"2789\" data-end=\"2938\">S.Koca, O.Ate&#351;, B.&Uuml;st&uuml;nda&#287;, U.&Ccedil;eliker, M.Ozgen, A.Isik. Der Prohepcidinspiegel im Serum bei Morbus Beh&ccedil;et. <em data-start=\"2890\" data-end=\"2921\">Turkiye Klinikleri J Med Sci.<\/em> 2008;28:601-605.<\/p>\n<\/li><li><p data-start=\"2940\" data-end=\"3135\">S. Koca, I. Karaca, M. F. Yavuzkir, N. Dagli, M. Ozgen, B. Ust&uuml;nda&#287;, A. I&#351;ik. Die Insulinresistenz steht im Zusammenhang mit oxidativem Stress beim systemischen Lupus erythematodes.  <em data-start=\"3095\" data-end=\"3119\">Anadolu Kardiyol Derg.<\/em>  2009;9(1):23-8.<\/p>\n<\/li><li><p data-start=\"3137\" data-end=\"3340\">S. Koca, E. O. Etem, B. Isik, H. Yuce, M. Ozgen, M. S. Dag, A. Isik. Pr&auml;valenz und Bedeutung von MEFV-Genmutationen in einer Patientenkohorte mit rheumatoider Arthritis.  <em data-start=\"3299\" data-end=\"3318\">Gelenk-Knochen-Wirbels&auml;ule.<\/em>  2010;77(1):32&ndash;5. (Q2)<\/p>\n<\/li><li><p data-start=\"3342\" data-end=\"3504\">Ozgen, S. S. Koca, A. Isik, I. H. Ozercan. Methotrexat zeigt bei der durch Bleomycin induzierten experimentellen Sklerodermie keine antifibrotische Wirkung.  <em data-start=\"3467\" data-end=\"3481\">J Rheumatol.<\/em>  2010;37(3):678&ndash;9. (Frage 1)<\/p>\n<\/li><li><p data-start=\"3506\" data-end=\"3696\">Akbulut, S. S. Koca, M. &Ouml;zgen, A. Isik. Therapien mit Anti-Tumor-Nekrose-Faktor senken den Serumspiegel des Makrophagen-Entz&uuml;ndungsproteins-1alpha bei ankylosierender Spondylitis.  <em data-start=\"3658\" data-end=\"3672\">J Rheumatol.<\/em>  2010;37(5):1073&ndash;4. (Frage 1)<\/p>\n<\/li><li><p data-start=\"3698\" data-end=\"3853\">Ozgen, S.S.Koca, N.Dagli, M.Balin, B.Ustundag, A.Isik. Adiponectin- und Vaspinspiegel im Serum bei rheumatoider Arthritis. <em data-start=\"3814\" data-end=\"3829\">Arch Med Res.<\/em> 2010;41(6):457-63. (Q1)  <\/p>\n<\/li><li><p data-start=\"3855\" data-end=\"4002\">Ozgen, S. S. Koca, E. O. Etem, H. Yuce, S. Aydin, A. Isik. Ghrelin-Genpolymorphismen bei rheumatoider Arthritis.  <em data-start=\"3959\" data-end=\"3978\">Gelenk-Knochen-Wirbels&auml;ule.<\/em>  2011;78(4):368&ndash;73. (Q2)<\/p>\n<\/li><li><p data-start=\"4004\" data-end=\"4174\">Ozgen, S.S.Koca, K.Aksoy, N.Dagli, B.Ustundag, A.Isik. Visfatinspiegel und Intima-Media-Dicke bei rheumatischen Erkrankungen. <em data-start=\"4127\" data-end=\"4150\">Klinische Rheumatologie<\/em> 2011;30(6):757-63. (Q2)  <\/p>\n<\/li><li><p data-start=\"4176\" data-end=\"4328\">Ozgen, S. S. Koca, N. Dagli, M. Balin, B. Ustundag, A. Isik. Der Serumspiegel von Salusin-alpha bei rheumatoider Arthritis.  <em data-start=\"4282\" data-end=\"4304\">Regulatorische Peptide.<\/em>  2011;167(1):125&ndash;8. (Q2)<\/p>\n<\/li><li><p data-start=\"4330\" data-end=\"4495\">Ozgen, S. S. Koca, B. Isik, N. Dagli, B. Ustundag, A. Isik. Adiponektin- und Vaspin-Spiegel im Serum bei systemischer Sklerose.  <em data-start=\"4443\" data-end=\"4477\">T&uuml;rkische Zeitschrift f&uuml;r Biochemie.<\/em>  2011;36(1);35-42.<\/p>\n<\/li><li><p data-start=\"4497\" data-end=\"4714\">S.Koca, M.Ozgen, F.Dagli, M.Tuzcu, I.H.Ozercan, K.Sahin, A.Isik. Antifibrotische Effekte der Proteasom-Inhibition bei Bleomycin-induzierter experimenteller Sklerodermie. <em data-start=\"4656\" data-end=\"4671\">Inflammation.<\/em> (2011) DOI: 10.1007\/s10753-011-9380-y (Q2) <\/p>\n<\/li><li><p data-start=\"4716\" data-end=\"5012\">Pehlivan, B.Gogebakan, S.Oztuzcu, M.Ozgen, G.Y.Cetin, R.Bayraktar, B.Kisacik, S.S.Koca, S.Donmez, M.Sayarlioglu, A.T.Demiryurek, A.M.Onat. Zusammenhang zwischen Thr21Met- und Ser89Asn-Polymorphismen des Urotensin-II-Gens und systemischer Sklerose. <em data-start=\"4960\" data-end=\"4974\">J Rheumatol.<\/em> (2011) DOI:10.3899\/jrheum.110509 (Q1) <\/p>\n<\/li><li><p data-start=\"5014\" data-end=\"5268\">Ozgen M, Koca SS, Dagli AF, Gundogdu B, Ustundag B, Isik A. Mycophenolat Mofetil und Daclizumab gegen T-Lymphozyten bei Bleomycin-induzierter experimenteller Sklerodermie.  <em data-start=\"5182\" data-end=\"5202\">Clin Exp Dermatol.<\/em>  Januar 2012; 37(1): 48&ndash;54. doi: 10.1111\/j.1365-2230.2011.04201.x. (Q2) <\/p>\n\n<p data-start=\"5275\" data-end=\"5315\"><strong data-start=\"5275\" data-end=\"5315\">Andere internationale Zeitschriftenartikel<\/strong><\/p>\n<\/li><li><p data-start=\"5317\" data-end=\"5534\">Yalcin Kehribar Demet, Ozgen M. The Experience of Interleukin-1 Inhibition in Patients with Familial Mediterranean Fever. <em data-start=\"5439\" data-end=\"5487\">Journal of Experimental and Clinical Medicine,<\/em> 38(1), 27-31. doi: 10.5835\/jecm.omu.38.01.006. <\/p>\n<\/li><li><p data-start=\"5536\" data-end=\"5836\">Yalcin Kehribar Demet, Okuyucu Muhammed, Ozgen Metin, Ketenci Yusuf Bunyam&#305;n, Ayy&#305;ld&#305;z Talat, Y&#305;ld&#305;r&#305;m Beytullah. Auswirkungen der Behandlung mit Tumor-Nekrose-Faktor-Alpha-Antagonisten auf den Antik&ouml;rpertiter des Hepatitis-B-Oberfl&auml;chenantigens. <em data-start=\"5759\" data-end=\"5793\">Journal of Surgery and Medicine,<\/em> 4(8), 678-681. doi: 10.28982\/josam.777871. <\/p>\n<\/li><li><p data-start=\"5838\" data-end=\"6140\">Yalcin Kehribar Demet, Izci Duran Tugba, Karakurt Cetinkaya Gamze, Kamal&#305; Polat Ayfer, Ozgen M. Evaluation of Symptoms, Depression and Anxiety Levels in Young Women with Idiopathic Granulomatous Mastitis. <em data-start=\"6043\" data-end=\"6101\">International Journal of Academic Medicine and Pharmacy,<\/em> 2(2), 57-61. doi: 0000-0002-1852-7981. <\/p>\n<p data-start=\"6147\" data-end=\"6208\"><strong data-start=\"6147\" data-end=\"6208\">Nationale Zeitschriftenartikel mit Peer-Review (T&Uuml;B&#304;TAK-Ulakbim)<\/strong><\/p>\n<\/li><li><p data-start=\"6210\" data-end=\"6425\">Demet Yal&ccedil;&#305;n Kehribar, Metin &Ouml;zgen. Klinische Merkmale von Patienten mit Gef&auml;&szlig;beteiligung bei der Beh&ccedil;et-Krankheit. <em data-start=\"6330\" data-end=\"6379\">Tepecik Training and Research Hospital Journal,<\/em> 2020;30(2):122-6. doi:10.5222\/terh.2020.86094  <\/p>\n<\/li><li><p data-start=\"6427\" data-end=\"6601\">&Ouml;zlem Evecen Eri&#351;mi&#351;, Demet Yal&ccedil;&#305;n Kehribar, Metin &Ouml;zgen. Vergleich von Patienten mit fr&uuml;h einsetzender und sp&auml;t einsetzender rheumatoider Arthritis. <em data-start=\"6557\" data-end=\"6581\">Firat Medical Journal,<\/em> 2020;25(4):179-183. <\/p>\n<\/li><li><p data-start=\"6603\" data-end=\"6825\">K.Poyrazo&#287;lu, A.Do&#287;ukan, S.S.Koca, M.&Ouml;zgen, A.&#304;.G&uuml;nal, H.G. Poyrazo&#287;lu. Zwei Geschwister mit famili&auml;rer juveniler hyperurik&auml;mischer Nephropathie: Ein Fallbericht. <em data-start=\"6753\" data-end=\"6810\">Turkish Nephrology Dialysis and Transplantation Journal<\/em> 2003:12;233-5.<\/p>\n<\/li><li><p data-start=\"6827\" data-end=\"7025\">&Ccedil;elebi, A.Karao&#287;lu, H.&Ccedil;elik, E.T. Elk&#305;ran, S.Yaz&#305;c&#305;, M.&Ouml;zgen, &#304;.H. &Ouml;zercan. Fr&uuml;hes intramukosales Magenkarzinom mit Krukenberg-Tumor: Ein Fallbericht. <em data-start=\"6975\" data-end=\"7010\">Firat University Medical Journal,<\/em> 2005:10;182-4.<\/p>\n<\/li><li><p data-start=\"7027\" data-end=\"7234\">S.Koca, A.I&#351;&#305;k, H.&Ccedil;eliker, M.&Ouml;zgen. Ulcerative Pyoderma Gangrenosum und CIDP in Verbindung mit chronischer Niereninsuffizienz: Ein Fallbericht und Literatur&uuml;bersicht. <em data-start=\"7180\" data-end=\"7215\">Firat University Medical Journal,<\/em> 2008;8(6):363-368.<\/p>\n<\/li><li><p data-start=\"7236\" data-end=\"7397\">S.Koca, M.&Ouml;zgen, A.I&#351;&#305;k. Experimentelle Tiermodelle bei Sklerodermie. <em data-start=\"7304\" data-end=\"7381\">Turkiye Klinikleri Journal of Immunology and Rheumatology - Special Topics,<\/em> 2009;2(3):50-7.<\/p>\n<\/li><li><p data-start=\"7399\" data-end=\"7581\">&Ouml;zgen, Y.&Ouml;zkan, S.S.Koca, A.I&#351;&#305;k. Die Auswirkungen von Lebensstil&auml;nderungen, Sibutramin und Orlistat bei fettleibigen Erwachsenen. <em data-start=\"7509\" data-end=\"7564\">Turkiye Klinikleri Journal of Cardiovascular Science,<\/em> 2010;22(1):12-8.<\/p>\n<\/li><li><p data-start=\"7583\" data-end=\"7708\">&Ouml;zgen, S.S.Koca. &Auml;tiopathogenese und aktuelle Behandlung der Sklerodermie. <em data-start=\"7655\" data-end=\"7690\">Firat University Medical Journal,<\/em> 2010;24(1):69-76. <\/p>\n<p data-start=\"7710\" data-end=\"7862\">S.Koca, M.&Ouml;zgen, A.I&#351;&#305;k. Behandlung bei Autoimmunkrankheiten. <em data-start=\"7769\" data-end=\"7846\">Turkiye Klinikleri Journal of Immunology and Rheumatology - Special Topics,<\/em> 2011;4(2):92-8.<\/p>\n\n<p data-start=\"7869\" data-end=\"7943\"><strong data-start=\"7869\" data-end=\"7943\">Auf internationalen wissenschaftlichen Konferenzen pr&auml;sentierte und ver&ouml;ffentlichte Abstracts<\/strong><\/p>\n<\/li><li><p data-start=\"7945\" data-end=\"8234\">S.Koca, E.O.Etem, B.Isik, H.Yuce, S.Dag, M.Ozgen, A.Isik. Pr&auml;valenz und Bedeutung von MEFV-Genmutationen in einer Kohorte von Patienten mit rheumatoider Arthritis. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2008, Paris, 11-14 Juni 2008. <em data-start=\"8183\" data-end=\"8213\">Annals of Rheumatic Diseases<\/em> EULAR 2008 (145 S.)  <\/p>\n<\/li><li><p data-start=\"8236\" data-end=\"8473\">S.Koca, M.Ozgen, S.Aydin, S.Dag, A.Isik. Vermindertes Ghrelin und erh&ouml;htes Obestatin bei rheumatoider Arthritis. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2008, Paris, 11-14 Juni 2008. <em data-start=\"8422\" data-end=\"8452\">Annals of Rheumatic Diseases<\/em> EULAR 2008 (289 S.)  <\/p>\n<\/li><li><p data-start=\"8475\" data-end=\"8778\">Ozgen, S. Koca, F. Dagli, K. Metin, B. Evren, A. Isik. Sch&uuml;tzende Wirkung von Mycophenolat Mofetil und Daclizumab bei Bleomycin-induzierter experimenteller Sklerodermie. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2009, Kopenhagen, D&auml;nemark, 10-13 Juni 2009. <em data-start=\"8723\" data-end=\"8753\">Annals of Rheumatic Diseases<\/em> EULAR 2009 (212-213 S.)  <\/p>\n<\/li><li><p data-start=\"8780\" data-end=\"9061\">Ozgen, S. Koca, F. Dagli, H. Akbulut, S. Dag, A. Isik. Methotrexat hat keine antifibrotische Wirkung bei Bleomycin-induzierter experimenteller Sklerodermie. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2009, Kopenhagen, D&auml;nemark, 10-13 Juni 2009. <em data-start=\"9010\" data-end=\"9040\">Annals of Rheumatic Diseases<\/em> EULAR 2009 (213 S.)  <\/p>\n<\/li><li><p data-start=\"9063\" data-end=\"9353\">Ozgen, S. Koca, F. Dagli, B. Isik, I. Ozercan, A. Isik. Sch&uuml;tzende Wirkung von Bevacizumab und Genistein bei Bleomycin-induzierter experimenteller Sklerodermie. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2009, Kopenhagen, D&auml;nemark, 10-13 Juni 2009. <em data-start=\"9302\" data-end=\"9332\">Annals of Rheumatic Diseases<\/em> EULAR 2009 (213 S.)  <\/p>\n<\/li><li><p data-start=\"9355\" data-end=\"9654\">Aksoy, M.Ozgen, S.Koca, N.Dagli, B.Ustundag, A.Isik. Visfatinspiegel und Intima-Media-Dicke bei rheumatoider Arthritis und systemischem Lupus erythematodes. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2009, Kopenhagen, D&auml;nemark, 10-13 Juni 2009. <em data-start=\"9603\" data-end=\"9633\">Annals of Rheumatic Diseases<\/em> EULAR 2009 (570 S.)  <\/p>\n<\/li><li><p data-start=\"9656\" data-end=\"9927\">Ozgen, S.Koca, E.O.Etem, H.Yuce, S.Aydin, A.Isik. Die Rolle von Ghrelin-Gen-Polymorphismen bei Patienten mit rheumatoider Arthritis. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2009, Kopenhagen, D&auml;nemark, 10-13 Juni 2009. <em data-start=\"9876\" data-end=\"9906\">Annals of Rheumatic Diseases<\/em> EULAR 2009 (727 S.)  <\/p>\n<\/li><li><p data-start=\"9929\" data-end=\"10205\">S.Koca, M.Ozgen, I.Ozercan, F.Dagli, B.Ustundag, A.Isik. Antifibrotische Effekte der Proteasom-Inhibition bei Bleomycin-induzierter experimenteller Sklerodermie. 1. Weltkongress f&uuml;r systemische Sklerose, Florenz Italien, 11-13 Februar 2010. <em data-start=\"10156\" data-end=\"10196\">Klinische und experimentelle Rheumatologie<\/em> (32 S.)  <\/p>\n<\/li><li><p data-start=\"10207\" data-end=\"10478\">Ozgen, S.S.Koca, B.Ustundag, I.Ozercan, F.Dagli, A.Isik. Antifibrotische Effekte von Cyclophosphamid bei Bleomycin-induzierter experimenteller Sklerodermie. 1. Weltkongress f&uuml;r systemische Sklerose, Florenz Italien, 11-13 Februar 2010. <em data-start=\"10429\" data-end=\"10469\">Klinische und experimentelle Rheumatologie<\/em> (89 S.)  <\/p>\n<\/li><li><p data-start=\"10480\" data-end=\"10714\">Ozgen, S.S.Koca, B.Isik, N.Dagli, B.Ustundag, A.Isik. Adiponectin- und Vaspinspiegel bei systemischer Sklerose. 1. Weltkongress f&uuml;r systemische Sklerose, Florenz, Italien, 11-13 Februar 2010. <em data-start=\"10664\" data-end=\"10704\">Klinische und experimentelle Rheumatologie<\/em> (103 S.)  <\/p>\n<\/li><li><p data-start=\"10716\" data-end=\"10946\">Ozgen, S.S.Koca, B.Isik, N.Dagli, B.Ustundag, A.Isik. Der Salusin-alpha-Spiegel im Serum bei systemischer Sklerose. 1. Systemische Sklerose Weltkongress. Florenz Italien, 11-13 Februar 2010. <em data-start=\"10895\" data-end=\"10935\">Klinische und experimentelle Rheumatologie<\/em> (p103 pp.)   <\/p>\n<\/li><li><p data-start=\"10948\" data-end=\"11200\">Ozgen, S.S.Koca, N.Dagli, M.Balin, B.Ustundag, A.Isik. Serum-Salusin-&alpha;-Spiegel bei Patienten mit rheumatoider Arthritis. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2010, Rom, Italien, 16-19 Juni 2010. <em data-start=\"11149\" data-end=\"11179\">Annals of Rheumatic Diseases<\/em> EULAR 2010 (516 S.)  <\/p>\n<\/li><li><p data-start=\"11202\" data-end=\"11479\">Ozgen, S.S.Koca, B.Isik, B.Ustundag, A.F.Dagli, A.Isik. Effektivit&auml;t der Gemcitabin-Behandlung bei Bleomycin-induzierter experimenteller Sklerodermie. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2010, Rom, Italien, 16-19 Juni 2010. <em data-start=\"11428\" data-end=\"11458\">Annals of Rheumatic Diseases<\/em> EULAR 2010 (419 S.)  <\/p>\n<\/li><li><p data-start=\"11481\" data-end=\"11761\">Ozgen, S.S.Koca, M.Sarikaya, I.H. Ozercan, B.Ustundag, A.Isik. Effektivit&auml;t der Ghrelin-Behandlung bei Bleomycin-induzierter experimenteller Sklerodermie. Europ&auml;ischer Jahreskongress f&uuml;r Rheumatologie, EULAR 2010, Rom, Italien, 16-19 Juni 2010. <em data-start=\"11710\" data-end=\"11740\">Annals of Rheumatic Diseases<\/em> EULAR 2010 (419 S.)  <\/p>\n\n \t<\/li><li data-start=\"286\" data-end=\"574\">\n<p data-start=\"288\" data-end=\"574\">Ozgen, S., S.S. Koca, Y. Dik, B. Ustundag, I.H. Ozercan, A. Isik.  <em data-start=\"354\" data-end=\"439\">Wirksamkeit der Rituximab-Behandlung bei Bleomycin-induzierter experimenteller Sklerodermie.<\/em>  J&auml;hrlicher Europ&auml;ischer Rheumatologiekongress, EULAR 2010, Rom, Italien, 16. bis 19. Juni 2010. Annals of Rheumatic Diseases EULAR 2010 (S. 419).<\/p>\n<\/li>\n \t<li data-start=\"576\" data-end=\"841\">\n<p data-start=\"578\" data-end=\"841\">Ozgen, S., S.S. Koca, M. Balin, M.N. Dagli, B. Ustundag, A. Isik.  <em data-start=\"644\" data-end=\"706\">Adiponectin- und Vaspinspiegel im Serum bei rheumatoider Arthritis.<\/em>  J&auml;hrlicher Europ&auml;ischer Rheumatologiekongress, EULAR 2010, Rom, Italien, 16. bis 19. Juni 2010. Annals of Rheumatic Diseases EULAR 2010 (S. 677).<\/p>\n<\/li>\n \t<li data-start=\"843\" data-end=\"1107\">\n<p data-start=\"845\" data-end=\"1107\">Ozgen, S., S.S. Koca, N. Dagli, M. Balin, B. Ustundag, A. Isik.  <em data-start=\"909\" data-end=\"967\">Adiponectin- und Vaspinspiegel im Serum bei Morbus Beh&ccedil;et.<\/em>  Die 14. Internationale Konferenz zum Beh&ccedil;et-Syndrom, Queen Mary College, University of London, 8. bis 10. Juli 2010. Tagungsband (S. 62&ndash;63).<\/p>\n<\/li>\n \t<li data-start=\"1109\" data-end=\"1362\">\n<p data-start=\"1111\" data-end=\"1362\">Ozgen, S., S.S. Koca, N. Dagli, M. Yavuzkir, B. Ustundag, A. Isik.  <em data-start=\"1178\" data-end=\"1222\">Salusin-&alpha;-Spiegel im Serum bei Morbus Beh&ccedil;et.<\/em>  Die 14. Internationale Konferenz zum Beh&ccedil;et-Syndrom, Queen Mary College, University of London, 8. bis 10. Juli 2010. Tagungsband (S. 63&ndash;64).<\/p>\n<\/li>\n<\/ul>\n\n\n\n<h3 data-start=\"1369\" data-end=\"1414\">Nationaler Kongress und Symposium Abstracts<\/h3>\n<ul data-start=\"1416\" data-end=\"5642\">\n \t<li data-start=\"1416\" data-end=\"1657\">\n<p data-start=\"1418\" data-end=\"1657\">Karaoglu, S., &Ccedil;elebi, H., &Ccedil;elik, H., Ataseven, S., Yazici, M., Ozgen, I.H. Ozercan.  <em data-start=\"1502\" data-end=\"1562\">Fr&uuml;hes Magenkarzinom mit Krukenberg-Tumor: Ein Fallbericht.<\/em>  4. Ost-S&uuml;dost-Anatolien Hepato-Gastroenterologie Symposium, 3-6 Juni 2004, Elazig (S. 78).<\/p>\n<\/li>\n \t<li data-start=\"1659\" data-end=\"1856\">\n<p data-start=\"1661\" data-end=\"1856\">Karaoglu, E.T., Elkiran, E., Topkan, M., Ozgen, A., Gencaslan, B., Evren.  <em data-start=\"1735\" data-end=\"1777\">Epidermoid-Brustkrebs: Ein Fallbericht.<\/em>  3. Nationaler Kongress f&uuml;r medizinische Onkologie, 6-10 September 2006, Antalya (S. 60).<\/p>\n<\/li>\n \t<li data-start=\"1858\" data-end=\"2073\">\n<p data-start=\"1860\" data-end=\"2073\">&Ouml;zkan, M., Ozgen, B., Ust&uuml;ndag, R., Colak.  <em data-start=\"1903\" data-end=\"1991\">Auswirkungen der Behandlung mit Orlistat und Sibutramin auf den Adiponectin- und Ghrelinspiegel im Serum.<\/em>  8. Nationaler Kongress f&uuml;r Innere Medizin, 13-17 September 2006, Antalya (S. 204).<\/p>\n<\/li>\n \t<li data-start=\"2075\" data-end=\"2314\">\n<p data-start=\"2077\" data-end=\"2314\">S. Koca, M. Ozgen, A.F. Dagli, I.H. Ozercan, A. Isik.  <em data-start=\"2131\" data-end=\"2239\">Wirksamkeit von Genistein- und Bevacizumab-Behandlungen im Bleomycin-induzierten experimentellen Sklerodermie-Modell.<\/em>  9. Nationaler Rheumatologie-Kongress, 11-15 Oktober 2008, Antalya (S. 117).<\/p>\n<\/li>\n \t<li data-start=\"2316\" data-end=\"2545\">\n<p data-start=\"2318\" data-end=\"2545\">Ozgen, S., S.S. Koca, A.F. Dagli, S. Dag, A. Isik.  <em data-start=\"2369\" data-end=\"2470\">Methotrexat zeigt keine antifibrotische Wirkung im Bleomycin-induzierten experimentellen Sklerodermie-Modell.<\/em>  9. Nationaler Rheumatologie-Kongress, 11-15 Oktober 2008, Antalya (S. 118).<\/p>\n<\/li>\n \t<li data-start=\"2547\" data-end=\"2806\">\n<p data-start=\"2549\" data-end=\"2806\">Ozgen, S., S.S. Koca, A.F. Dagli, K. Metin, B. Evren, A. Isik.  <em data-start=\"2612\" data-end=\"2731\">Wirksamkeit der Behandlung mit Daclizumab und Mycophenolatmofetil im Bleomycin-induzierten experimentellen Sklerodermie-Modell.<\/em>  9. Nationaler Rheumatologie-Kongress, 11-15 Oktober 2008, Antalya (S. 121).<\/p>\n<\/li>\n \t<li data-start=\"2808\" data-end=\"3065\">\n<p data-start=\"2810\" data-end=\"3065\">Aksoy, S., S.S. Koca, M. Ozgen, N. Dagli, B. Ustundag, A. Isik.  <em data-start=\"2874\" data-end=\"2990\">Visfatinspiegel und Intima-Media-Dicke bei Patienten mit rheumatoider Arthritis und systemischem Lupus erythematosus.<\/em>  9. Nationaler Rheumatologie-Kongress, 11-15 Oktober 2008, Antalya (S. 138).<\/p>\n<\/li>\n \t<li data-start=\"3067\" data-end=\"3308\">\n<p data-start=\"3069\" data-end=\"3308\">S. Koca, M. Ozgen, E.O. Etem, H. Y&uuml;ce, S. Aydin, A. Isik.  <em data-start=\"3127\" data-end=\"3233\">H&auml;ufigkeit und klinische Bedeutung von Ghrelin-Gen-Polymorphismen bei Patienten mit rheumatoider Arthritis.<\/em>  9. Nationaler Rheumatologie-Kongress, 11-15 Oktober 2008, Antalya (S. 139).<\/p>\n<\/li>\n \t<li data-start=\"3310\" data-end=\"3519\">\n<p data-start=\"3312\" data-end=\"3519\">Ozgen, S., S.S. Koca, N. Dagli, K. Metin, A. Isik.  <em data-start=\"3363\" data-end=\"3444\">Visfatinspiegel und Intima-Media-Dicke bei Morbus Behcet und Sklerodermie.<\/em>  9. Nationaler Rheumatologie-Kongress, 11-15 Oktober 2008, Antalya (S. 145).<\/p>\n<\/li>\n \t<li data-start=\"3521\" data-end=\"3769\">\n<p data-start=\"3523\" data-end=\"3769\">Akbulut, M., Ozgen, S.S. Koca, B. Evren, A. Isik.  <em data-start=\"3573\" data-end=\"3696\">Auswirkungen einer Anti-TNF-Behandlung auf den Chemokinspiegel im Serum bei Patienten mit rheumatoider Arthritis und ankylosierender Spondylitis.<\/em>  33rd Turkish Microbiology Congress, 21-25 Oktober 2008, Izmir (S. 174).<\/p>\n<\/li>\n \t<li data-start=\"3771\" data-end=\"4079\">\n<p data-start=\"3773\" data-end=\"4079\">O. Karadag, S. Yilmaz, B. Kisacik, U. Kalyoncu, E. Tezcan, S. Yilmaz, M. Ozgen, D. Ka&#351;kar&#305;, H. Direskeneli, H. Kiraz, I. Erteneli, A. Din&ccedil;.  <em data-start=\"3913\" data-end=\"4010\">Raten und Gr&uuml;nde f&uuml;r den Wechsel von biologischen Arzneimitteln bei rheumatischen Erkrankungen: Ergebnisse von RomaDigital.<\/em>  Nationaler Rheumatologie-Kongress, 13-17 Oktober 2010, Antalya (7 S.).<\/p>\n<\/li>\n \t<li data-start=\"4081\" data-end=\"4396\">\n<p data-start=\"4083\" data-end=\"4396\">Pehlivan, B., Gogebakan, S., Oztuzcu, M., Ozgen, G.Y., Cetin, B., Cengiz, B., Kisacik, S.S., Koca, &Ouml;.N., Pamuk, M., Sayarlioglu, A.T., Demiryurek, A.M. <em data-start=\"4235\" data-end=\"4326\">Relationship between systemic sclerosis and urotensin-II gene T21 and S89N polymorphisms.<\/em> Nationaler Rheumatologie-Kongress, 13-17 Oktober 2010, Antalya (27 S.).<\/p>\n<\/li>\n \t<li data-start=\"4398\" data-end=\"4691\">\n<p data-start=\"4400\" data-end=\"4691\">Ozgen, S., S.S. Koca, A.F. Dagli, A. Karatas, C. Orhan, H. Genco&#287;lu, N. Sahin, K. Sahin, A. Isik.  <em data-start=\"4498\" data-end=\"4616\">Vorbeugende und therapeutische Wirkungen von Epigallocatechin-3-Gallat (EGCG) im Modell der Kollagen-induzierten Arthritis bei Ratten.<\/em>  12. Nationaler Rheumatologie-Kongress, 16-20 Oktober 2011, Antalya (S. 84).<\/p>\n<\/li>\n \t<li data-start=\"4693\" data-end=\"4948\">\n<p data-start=\"4695\" data-end=\"4948\">Ozgen, S., S.S. Koca, A.F. Dagli, A. Karatas, C. Orhan, M. Tuzcu, N. Sahin, K. Sahin, A. Isik.  <em data-start=\"4790\" data-end=\"4870\">Therapeutische Wirkung von Gemcitabin bei Kollagen-induzierter Arthritis bei Ratten.<\/em>  12. Nationaler Rheumatologie-Kongress, 16-20 Oktober 2011, Antalya (S. 84-85).<\/p>\n<\/li>\n \t<li data-start=\"4950\" data-end=\"5198\">\n<p data-start=\"4952\" data-end=\"5198\">Ozgen, S., S.S. Koca, A. Karatas, A.F. Dagli, F. Erman, B. Gundogdu, K. Sahin, A. Isik.  <em data-start=\"5040\" data-end=\"5123\">Wirksamkeit der Lapatinib-Behandlung im Kollagen-induzierten Arthritis-Modell bei Ratten.<\/em>  12. Nationaler Rheumatologie-Kongress, 16-20 Oktober 2011, Antalya (S. 24).<\/p>\n<\/li>\n \t<li data-start=\"5200\" data-end=\"5446\">\n<p data-start=\"5202\" data-end=\"5446\">Ozgen, S., S.S. Koca, A. Karatas, A.F. Dagli, F. Erman, N. Sahin, K. Sahin, A. Isik.  <em data-start=\"5287\" data-end=\"5371\">Wirksamkeit der Behandlung mit Pemetrexed bei kollagen-induzierter Arthritis in Ratten.<\/em>  12. Nationaler Rheumatologie-Kongress, 16-20 Oktober 2011, Antalya (S. 79).<\/p>\n<\/li>\n \t<li data-start=\"5448\" data-end=\"5642\">\n<p data-start=\"5450\" data-end=\"5642\">Ozgen, S., S.S. Koca, F. Akbas, N. Ilhan, A. Karatas, A. Isik.  <em data-start=\"5513\" data-end=\"5563\">Serum-Galektin-3-Spiegel bei Sklerodermie-Patienten.<\/em>  12. Nationaler Rheumatologie-Kongress, 16-20 Oktober 2011, Antalya (S. 99-100).<\/p>\n<\/li>\n<\/ul>\n\n\n\n<h3 data-start=\"5649\" data-end=\"5712\">Nationale Abstracts w&auml;hrend der Associate-Professur ver&ouml;ffentlicht<\/h3>\n<ul data-start=\"5714\" data-end=\"6202\">\n \t<li data-start=\"5714\" data-end=\"5851\">\n<p data-start=\"5716\" data-end=\"5851\">Kehribar, M., Ozgen.  <em data-start=\"5737\" data-end=\"5785\">Sp&auml;t auftretende F&auml;lle von famili&auml;rem Mittelmeerfieber.<\/em>  19. Nationaler Rheumatologie-Kongress, 26-30 September 2018, Izmir.<\/p>\n<\/li>\n \t<li data-start=\"5853\" data-end=\"6064\">\n<p data-start=\"5855\" data-end=\"6064\">Kehribar, M.&#350;. Altuner, M. Ozgen. <em data-start=\"5889\" data-end=\"5998\">Ein Fall von generalisierter Morphea, der mit der Diagnose eosinophile Fasziitis und systemische Sklerose verwechselt werden kann.<\/em> 19. Nationaler Rheumatologie-Kongress, 26-30 September 2018, Izmir.<\/p>\n<\/li>\n \t<li data-start=\"6066\" data-end=\"6202\">\n<p data-start=\"6068\" data-end=\"6202\">Kehribar, M., Ozgen, M. Yilmaz.  <em data-start=\"6100\" data-end=\"6131\">Sp&auml;ter Beginn oder sp&auml;te Diagnose?<\/em>  20. Nationaler Kongress f&uuml;r Innere Medizin, 10-14 Oktober 2018, Antalya.<\/p>\n<\/li>\n<\/ul>\n\n<h3 data-start=\"6209\" data-end=\"6262\">W&auml;hrend der Professur ver&ouml;ffentlichte nationale Abstracts<\/h3>\n<ul data-start=\"6264\" data-end=\"6881\">\n \t<li data-start=\"6264\" data-end=\"6427\">\n<p data-start=\"6266\" data-end=\"6427\">Demet Yal&ccedil;&#305;n Kehribar, Zontul Sezgin, Ozgen Metin (2018).  <em data-start=\"6324\" data-end=\"6372\">Sp&auml;t auftretende F&auml;lle von famili&auml;rem Mittelmeerfieber.<\/em>  19. Nationaler Rheumatologie-Kongress (Abstract\/Poster).<\/p>\n<\/li>\n \t<li data-start=\"6429\" data-end=\"6577\">\n<p data-start=\"6431\" data-end=\"6577\">Demet Yal&ccedil;&#305;n Kehribar, Merve Yilmaz, Ozgen Metin (2018).  <em data-start=\"6488\" data-end=\"6522\">Seltener Fall von systemischer Mastozytose.<\/em>  19. Nationaler Rheumatologie-Kongress (Abstract\/Poster).<\/p>\n<\/li>\n \t<li data-start=\"6579\" data-end=\"6727\">\n<p data-start=\"6581\" data-end=\"6727\">Demet Yal&ccedil;&#305;n Kehribar, Merve Yilmaz, Ozgen Metin (2018).  <em data-start=\"6638\" data-end=\"6672\">Seltener Fall von systemischer Mastozytose.<\/em>  19. Nationaler Rheumatologie-Kongress (Abstract\/Poster).<\/p>\n<\/li>\n \t<li data-start=\"6729\" data-end=\"6881\">\n<p data-start=\"6731\" data-end=\"6881\">Demet Yal&ccedil;&#305;n Kehribar, Metin Ozgen, Merve Yilmaz.  <em data-start=\"6781\" data-end=\"6812\">Sp&auml;ter Beginn oder sp&auml;te Diagnose?<\/em>  20. Nationaler Kongress f&uuml;r Innere Medizin, Antalya (Abstract\/Poster).<\/p>\n<\/li>\n<\/ul>\n\n\n<h3 data-start=\"6888\" data-end=\"6923\">Autorschaft f&uuml;r t&uuml;rkische Buchkapitel<\/h3>\n<ul data-start=\"6925\" data-end=\"7687\">\n \t<li data-start=\"6925\" data-end=\"7057\">\n<p data-start=\"6927\" data-end=\"7057\">Ozgen, D.Y. Kehribar, S. Kir.  <em data-start=\"6957\" data-end=\"7017\">Ein 55-j&auml;hriger m&auml;nnlicher Patient mit wandernden Schmerzbeschwerden.<\/em>  Klinische Rheumatologie mit Fallbeispielen, 2019.<\/p>\n<\/li>\n \t<li data-start=\"7059\" data-end=\"7204\">\n<p data-start=\"7061\" data-end=\"7204\">Kir, M., Ozgen.  <em data-start=\"7077\" data-end=\"7164\">Ein 42-j&auml;hriger m&auml;nnlicher Patient mit 2 Monaten Fieber, Schwitzen, Gewichtsverlust und M&uuml;digkeit.<\/em>  Klinische Rheumatologie mit Fallbeispielen, 2019.<\/p>\n<\/li>\n \t<li data-start=\"7206\" data-end=\"7388\">\n<p data-start=\"7208\" data-end=\"7388\">Yal&ccedil;&#305;n Kehribar D., Ozgen M. <em data-start=\"7237\" data-end=\"7265\">Autoinflammatory Diseases.<\/em> Clinical Rheumatology, K&#305;sac&#305;k B&uuml;nyamin, Bes Cemal, Koca S&uuml;leyman Serdar (Editors), T&uuml;rkiye Klinikleri, pp. 550-555, 2021.<\/p>\n<\/li>\n \t<li data-start=\"7390\" data-end=\"7602\">\n<p data-start=\"7392\" data-end=\"7602\">Kehribar L., Ozgen M. <em data-start=\"7414\" data-end=\"7479\">Akutes rheumatisches Fieber und poststreptokokkale reaktive Arthritis.<\/em> Clinical Rheumatology, K&#305;sac&#305;k B&uuml;nyamin, Bes Cemal, Koca S&uuml;leyman Serdar (Editors), T&uuml;rkiye Klinikleri, pp. 642-649, 2021.<\/p>\n<\/li>\n \t<li data-start=\"7604\" data-end=\"7647\">\n<p data-start=\"7606\" data-end=\"7647\">Metin Ozgen.  <em data-start=\"7619\" data-end=\"7647\">Aneurysmen in der Rheumatologie.<\/em><\/p>\n<\/li>\n \t<li data-start=\"7649\" data-end=\"7687\">\n<p data-start=\"7651\" data-end=\"7687\">Metin Ozgen.  <em data-start=\"7664\" data-end=\"7687\">Metabolische Myopathien.<\/em><\/p>\n<\/li>\n<\/ul>\n\n<h3 data-start=\"7694\" data-end=\"7715\">Betreute Abschlussarbeiten<\/h3>\n<ul data-start=\"7717\" data-end=\"7994\">\n \t<li data-start=\"7717\" data-end=\"7854\">\n<p data-start=\"7719\" data-end=\"7854\">Fatih Tay, 2016.  <em data-start=\"7736\" data-end=\"7854\">Untersuchung m&ouml;glicher Faktoren f&uuml;r die Umstellung auf eine Anti-TNF-Therapie bei Patienten mit ankylosierender Spondylitis.<\/em><\/p>\n<\/li>\n \t<li data-start=\"7856\" data-end=\"7994\">\n<p data-start=\"7858\" data-end=\"7994\">&Ouml;zlem Evecen, 2019.  <em data-start=\"7878\" data-end=\"7994\">Auswertung der klinischen, demographischen und medizinischen Behandlungen von Patienten mit fr&uuml;h und sp&auml;t einsetzender rheumatoider Arthritis.<\/em><\/p>\n<\/li>\n<\/ul>\n\n<h3 data-start=\"8001\" data-end=\"8035\">Projekte und Rollen in Projekten<\/h3>\n<ul data-start=\"8037\" data-end=\"9340\">\n \t<li data-start=\"8037\" data-end=\"8192\">\n<p data-start=\"8039\" data-end=\"8192\"><em data-start=\"8039\" data-end=\"8126\">Auswirkung der Behandlung mit Orlistat und Sibutramin auf die Adiponectin- und Ghrelinspiegel im Serum.<\/em>  (F&Uuml;BAP-Firat Universit&auml;t Wissenschaftliche Forschungsprojekte: Forscher)<\/p>\n<\/li>\n \t<li data-start=\"8194\" data-end=\"8302\">\n<p data-start=\"8196\" data-end=\"8302\"><em data-start=\"8196\" data-end=\"8236\">Serum-Galektin-3-Spiegel bei Sklerodermie.<\/em>  (F&Uuml;BAP-Firat Universit&auml;t Wissenschaftliche Forschungsprojekte: Forscher)<\/p>\n<\/li>\n \t<li data-start=\"8304\" data-end=\"8492\">\n<p data-start=\"8306\" data-end=\"8492\"><em data-start=\"8306\" data-end=\"8426\">Auswirkungen von Omentin und Apelin auf die Insulinresistenz bei Patienten mit rheumatoider Arthritis und systemischem Lupus erythematodes.<\/em>  (F&Uuml;BAP-Firat Universit&auml;t Wissenschaftliche Forschungsprojekte: Forscher)<\/p>\n<\/li>\n \t<li data-start=\"8494\" data-end=\"8616\">\n<p data-start=\"8496\" data-end=\"8616\"><em data-start=\"8496\" data-end=\"8550\">Lapatinib-Behandlung in experimentellem Arthritis-Modell.<\/em>  (F&Uuml;BAP-Firat Universit&auml;t Wissenschaftliche Forschungsprojekte: Forscher)<\/p>\n<\/li>\n \t<li data-start=\"8618\" data-end=\"8741\">\n<p data-start=\"8620\" data-end=\"8741\"><em data-start=\"8620\" data-end=\"8675\">Pemetrexed-Behandlung in experimentellem Arthritis-Modell.<\/em>  (F&Uuml;BAP-Firat Universit&auml;t Wissenschaftliche Forschungsprojekte: Forscher)<\/p>\n<\/li>\n \t<li data-start=\"8743\" data-end=\"8879\">\n<p data-start=\"8745\" data-end=\"8879\"><em data-start=\"8745\" data-end=\"8801\">Gemcitabin-Behandlung in experimentellem Arthritis-Modell.<\/em>  (F&Uuml;BAP-Firat University Wissenschaftliche Forschungsprojekte: Principal Investigator)<\/p>\n<\/li>\n \t<li data-start=\"8881\" data-end=\"9018\">\n<p data-start=\"8883\" data-end=\"9018\"><em data-start=\"8883\" data-end=\"8952\">IL-33-Spiegel im Serum und IL-33-Genpolymorphismen bei Morbus Beh&ccedil;et.<\/em>  (F&Uuml;BAP-Firat Universit&auml;t Wissenschaftliche Forschungsprojekte: Forscher)<\/p>\n<\/li>\n \t<li data-start=\"9020\" data-end=\"9194\">\n<p data-start=\"9022\" data-end=\"9194\"><em data-start=\"9022\" data-end=\"9128\">Ghrelin- und Obestatin-Spiegel im Serum, Ghrelin- und Ghrelin-Rezeptor-Gen-Polymorphismen bei Morbus Beh&ccedil;et.<\/em>  (F&Uuml;BAP-Firat Universit&auml;t Wissenschaftliche Forschungsprojekte: Forscher)<\/p>\n<\/li>\n \t<li data-start=\"9196\" data-end=\"9340\">\n<p data-start=\"9198\" data-end=\"9340\"><em data-start=\"9198\" data-end=\"9271\">IL-33-Serumspiegel und IL-33-Genpolymorphismen bei rheumatoider Arthritis.<\/em>  (RAED - Rheumatology Research and Education Association: Forscher)<\/p>\n<\/li>\n<\/ul>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Prof. Dr. med. Metin \u00d6zgen<\/p>\n","protected":false},"author":3,"featured_media":11007,"parent":14366,"menu_order":41,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[190],"tags":[171],"class_list":["post-15243","page","type-page","status-publish","has-post-thumbnail","hentry","category-rheumatologie","tag-medicalpoint-izmir-krankenhaus","bf-cat-190","bf-cat-544"],"rankMath":{"parentDomain":"medicalpointinternational.com","noFollowDomains":[],"noFollowExcludeDomains":[],"noFollowExternalLinks":false,"featuredImageNotice":"Das angezeigte Beitragsbild sollte mindestens 200x200 px gro\u00df sein, damit Facebook und andere Social-Media-Websites es \u00fcbernehmen.","pluginReviewed":false,"postSettings":{"linkSuggestions":true,"useFocusKeyword":false},"frontEndScore":false,"postName":"prof-metin-oezgen","permalinkFormat":"https:\/\/medicalpointinternational.com\/de\/%pagename%\/","showLockModifiedDate":true,"assessor":{"focusKeywordLink":"https:\/\/medicalpointinternational.com\/wp-admin\/edit.php?focus_keyword=%focus_keyword%&post_type=%post_type%","hasTOCPlugin":true,"primaryTaxonomy":false,"serpData":{"title":"","description":"","focusKeywords":"","pillarContent":false,"canonicalUrl":"","breadcrumbTitle":"","advancedRobots":{"max-snippet":"-1","max-video-preview":"-1","max-image-preview":"large"},"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":"","facebookHasOverlay":false,"facebookImageOverlay":"","facebookAuthor":"","twitterCardType":"","twitterUseFacebook":true,"twitterTitle":"","twitterDescription":"","twitterImage":"","twitterImageID":"","twitterHasOverlay":false,"twitterImageOverlay":"","twitterPlayerUrl":"","twitterPlayerSize":"","twitterPlayerStream":"","twitterPlayerStreamCtype":"","twitterAppDescription":"","twitterAppIphoneName":"","twitterAppIphoneID":"","twitterAppIphoneUrl":"","twitterAppIpadName":"","twitterAppIpadID":"","twitterAppIpadUrl":"","twitterAppGoogleplayName":"","twitterAppGoogleplayID":"","twitterAppGoogleplayUrl":"","twitterAppCountry":"","robots":{"index":true},"twitterAuthor":"Benutzername","primaryTerm":0,"authorName":"Ali \u00d6zgen\u00e7","titleTemplate":"%title% %sep% %sitename%","descriptionTemplate":"%excerpt%","showScoreFrontend":true,"lockModifiedDate":false},"powerWords":["abgelenkt","abgesturzt","absolut","abstossend","aburd","abweisen","adaquat","aggressiv","ahnungslos","akkurat","alarmierend","alarmiert","albtraum","all-inclusive","allererste","allererster","allererstes","alleswisser","am schlechtesten","am wichtigsten","angewidert","angriff","angsteinflossend","angstlich","animiert","ankundigung","anonym","anpassbar","anspruchslos","anstossig","antagonistisch","apokalypse","applaus","argumentativ","arm","armageddon","arrogant","atemberaubend","attacke","attraktiv","aufdeckend","aufgebracht","aufgedeckt","aufgeregt","aufheiternd","aufregend","aufregende","aufregenden","aufregung","aufstachelnd","aufstandisch","aufsteigend","auftreibend","augenoffnend","ausgelassen","ausgeruht","ausgespielt","ausgewahlt","ausgewuhlt","ausnutzen","aussergewohnlich","autark","authentisch","autoritat","backdoor","badass","beangstigend","bedenklich","bedingungslos","bedrohen","bedroht","beforderung","befreit","befriedigend","befriedigt","begehren","begeistern","begeistert","begeisterung","beherzt","behind the scenes","beichte","beleidigung","belohnung","bemerkenswert","beneiden","bequem","beruhmt","beschadigen","beschamend","beschmutzt","beschuldigen","beschutzen","besitz","bessesen","bestatigen","bestatigt","beste","bestimmt","bestrafen","betrug","betrugen","bewahrt","bewiesen","bewiesenermassen","bewusst","bezahlbar","bezaubernd","bizarre","bleich","blendend","blut","blutbad","blutig","bombe","bonanza","bonus","bosartig","bose","boshaft","brilliant","brodelnd","brutal","budget","bullshit","bully","bunt","bunte","bunten","case study","cash","challenge","challgene","chaos","cheat-sheet","clever","content","cool","courage","dankbar","daruber redet keiner","deadline","definitiv","dekadent","demoralisierend","demut","desillusioniert","detailiert","diagnose","die wahrheit","direkt","disastros","discount","dokument","dollar","dominieren","doppelt","download","dreckig","dreifach","dreistigkeit","dringend","dringlichkeit","dumm","dummkopf","dummlich","durchbruch","duselig","dynamik","echt","effektiv","effizient","ehrlich","eier","eifersuchtig","eifrig","eindeutig","eindrucksvoll","eine stufe besser","einfach","einfachheit","einfallsreich","eingebildet","eingeschrankt","eingesperrt","einmalig","einsam","eintauchen","einzigartig","eisern","eliminieren","elite","empathie","empfehle","empfehlen","endeffekt","energie","energisch","enorm","entdecken","entfesselt","entfremdet","enthullen","enthullung","enthusiastisch","entmachtet","entsetzlich","entspannt","entzuckend","entzunden","epidemisch","episch","erbarmlich","erfolg","erfolgreich","erfolgsbilanz","erfreut","erfullen","erfullt","ergebnisse","ergreifen","erhaben","erheben","erhohen","erledigt","ermachtigt","ermudet","ernmutigt","ernsthaft","erobern","erroten","errungenschaft","erschaffen","erschrocken","ersehnen","ersparnisse","erstattbar","erstatten","erstaunlich","erste","ertrinken","essentiell","ethisch","euphorisch","exakt","exklusiv","exklusivitat","exkuisit","experte","explodieren","explosiv","exposed","extrem","exzellent","fahig","fahigkeiten","fail","falle","fantasie","fantastischen","farbenfroh","farbenfrohe","faszinierend","faszinierende","faul","faux pas","faux","fehler","feindselig","feldstudie","fesselnd","festlich","festmahl","festplatte","final","flirt","fluchtling","flussig","fokus","fokussiert","folter","formel","frech","freebie","frei","freiheit","freudig","friedlich","frohlich","frohlichkeit","frustriert","fundamental","fur immer","furchtbar","furchtlos","gangster","garantiert","geblendet","geehrt","gefahr","gefahrlich","gefangen","gefangnis","gefeuert","gegensatzlich","gehassig","geheimnis","geheimnisse","geil","geisseln","geist","geistesgestort","gelassen","geld zuruck","geld","genial","gepackt","gerade angekommen","gerissen","geschenk","geschmuggelt","geschutzt","gestandnis","gestandnisse","gestopft","gestresst","gesucht","gesund","getauscht","getestet","getotet","gewaltig","gewalttatig","gewidmet","gewinnspiel","gier","gierig","gift","giftig","gigantisch","giveaway","glamourose","glanzend","glaube","glaubwurdig","gleichmassig","glittering","glitzernde","gluckselig","golden","grandios","grandiose","grandiosen","grandioses","grauenhaft","grausamkeit","grinsen","groesste","gross","grossartig","grossartig","grossartige","grossartigen","grossartiger","grossartiges","grosse","grossen","grosste","grosszugig","grotesk","grube","grundlegend","gruselig","gunstig","hack","hamisch","hammer","handelsgeheimnis","hartnackig","hass","heilig","heimlich","heisshunger","heisshungrig","heiter","held","hell","herablassend","herausfordernd","herausforderung","herausvorderung","herrlichen","herrschend","hervorragend","herz","herzbrechend","herzerwahrmend","heute","hightech","hilflosigkeit","hilfreich","hilfsbereit","himmlisch","hinterhaltig","hoax","hocheffektiv","hochnasig","hochste","hoffnung","hoffnungsvoll","holle","holocaust","horror","how to","humor","hungrige","hurrikan","hypnotisch","hypnotisierend","idiot","idiotisch","illegal","immer","informativ","inhalt","inkompetent","innovativ","insider","inspirierend","inspiriert","intelligent","intensiv","interessant","interessante","invasion","investment","ist da","jackpot","jederzeit kundigen","jetzt","jubilant","jumpstart","jung","kadaver","kampf","katapult","katastrophe","kaufen","kein risiko","keine verpflichtung","kickstart","kindisch","kitschig","klaglich","klar","knast","kollabieren","kollosal","komfortabel","komisch","kompetitiv","komplett","kompromiss","komsich","konstruktiv","kontrollierend","kontrollverlust","kooperativ","kopie","korrupt","kostenlos","kraftlos","kraftvoll","krankhaft","kreativ","kreative","kriese","kritisch","kruppel","lachen","lacherlich","lahm","last minute","lauernd","lebendig","lebenslanglich","lecken","lecker","legendar","legitim","leiche","leicht","leiden","leider","leise","letzte chance","letzte","leuchtend","liberal","licht","liebe","liebenswurdig","liebevoll","life-changing","limitiert","lohnend","loser","losung","lugen","lugend","lukrativ","lust","lustig","lustige","lustigsten","luxorios","magisch","mainstream","mammut","manipulativ","massiv","masterclass","meditierend","meiseter","meistverkauft","meltdown","millionen","mind-blowing","minderwertig","minimalist","missbrauch","misstrauisch","mittelmassig","mittig","modern","moderne","moglichkeiten","monetarisieren","monumental","mord","motiviert","muhelos","muhevoll","mull","mut","mutig","nachmachen","nachteile","nackt","nagel","naiv","natural","nazi","neid","nervos","neu","niedertrachtig","niemals","notfall","notiert","nutzlich","nutzlos","offensichtlich","offiziel","offnen","ohne hintergedanken","ok","okay","okonomisch","on-demand","opfer","optimistisch","overnight","packend","panik","panzer","paralisiert","pas","passioniert","pause","payback","peinlich","perfekt","perplex","perskeptive","pessimistisch","pfund","piranha","pleite","plotzlich","pochend","polarisierend","popular","portfolio","praktisch","preis","prestige","privat","privatsphare","priviligiert","problem","produktiv","professionell","profit","profitabel","provokativ","provozierend","prozess","psychologisch","qual","qualen","qualitat","rabatt","rache","rachsuchtig","raffiniert","rasend","rat","rau","recherche","reduziert","reflektieren","regeln","reich","reiche","reichtum","relaxed","report","responsive","revolutionar","riesig","risiko","riskant","riskieren","rotzfrech","rowdy","ruckrat","ruckschlag","rucksichtlos","ruhig","ruiniert","sabotiert","sadistisch","sale","sarkastisch","scam","schabig","schadigend","schadlich","schamlos","schatz","schicksal","schlachten","schlafen","schlag","schlau","schlimm","schmerzhaft","schmerzlos","schmuggel","schnell","schnellstart","schokierend","schonheit","schrecklich","schreien","schritt fur schritt","schuld","schuldlos","schwach","schwarm","schwarzmarkt","schwerkraft","schwinden","sechsstellig","sehenswerte","selbsthass","selten","sensationell","sex","sexy","sicher","sicherheit","sicherlich","sieg","sill","simpel","sinnlich","sinnlos","skandal","skandalos","skill","sklave","sneak-peek","snob","sofort gespart","sofort","sollte","sonnig","sonnige","sonnigen","sorgen","sorgfaltig","sorglos","spannend","sparen","sparsam","spass","spassig","spektakular","speziell","spielen","spoiler","spontan","spotlight","stabil","stark","start","stoisch","stolz","stop","strahlend","strangulieren","strategie","studien","stumperhaft","stur","sunden","sundigend","super","superb","survival","tapfer","tauschend","teaser","technologie","terror","terrorist","teuer","tief","tiefgreifend","tierisch","tod","todlich","toll","tolle","toller","tortur","tot","tote","toten","totend","toxisch","tragisch","tragodie","transfomieren","transparenz","trauma","traumatisiert","traurigkeit","trend","tricks","trigger","triumpf","trocken","trotz","trugerisch","tweaks","tyrann","ubel","uberfordert","uberkommen","uberleben","uberlegen","uberraschend","uberrascht","uberraschung","uberwaltigend","uberwinden","ultimativ","umfassend","umstritten","umwerfend","unatorisiert","unaufhaltbar","unausgelasted","unbedacht","unbeliebt","unbeschwert","unbewusst","undercover","undokumentiert","unehrlich","unentschlossen","unerwartet","unfahig","ungeduldig","ungedult","ungehort","ungemutlich","ungerechtfertigt","ungesehen","ungetrubt","ungewohnlich","ungezogen","unglaublich","unglaubliches","uninteressiert","unkontrollierbar","unkonventionell","unlimitiert","unpenetrierbar","unschuldig","unsicher","unstabil","unter verschluss","untergrund","unterhaltsam","unterstutz","unterstutzend","unubertroffen","unvergesslich","unverneinbar","unvoreingenommen","unwiderstehlich","unwirtlich","unzensiert","unzuverlassig","up-selling","vaporisieren","verangstigt","verantwortlich","verargert","verarscht","verbessert","verbluffend","verblufft","verboten","verbreiten","verdachtig","verdammt","verdeckt","vereinfacht","verfuhrend","vergebend","vergessen","vergleich","verhauen","verifizieren","verkommen","verlegen","verletzbar","verletzt","verlockend","verloren","vermasselt","vermeiden","vermogen","vernichten","vernichtend","vernunftig","veroffentlichung","verpassen","verraterisch","verruckt","versagen","verschwitzt","versichert","verspielt","versprechend","versteckt","vertrauenswurdig","vertraulich","vertraumt","verurteilend","verwunderlich","verwundet","verzaubernd","verzweifelt","vierfach","vogelfrei","vollig","vollstandig","vorsicht","vorstellungskraft","vorteil","wachstum","wagemutig","wahnsinn","wahnsinnig","wahrhaftig","wahrheit","wahrheitsgemass","wahrscheinlich","warnung","was dir keiner sagt","wehleidig","welt","wenig bekannt","wert","wertvoll","wichtig","widerlich","wiedererkannt","wild","wilde","wilden","willensstarke","wirr","wohltatigkeit","wortlich","wunder","wunderbar","wunderbaren","wunderschon","wutend","zeichen","zeitig","zen","zensiert","zerschlagen","zerschmetternd","zerstorend","zertifiziert","zielorientiert","zischend","zischt","zocken","zogernd","zugeben","zuruckgehalten","zuruckgelassen","zuruckweisen","zusatzlich","zutaten","zuverlassig","zwangsernahrt","zweifelnd","zwickend","zwingend","einfache","einfachen","einfaches","einfacher","simple","simplen","simples","simpler","besten","bestes","bester","beste","bestbewertet","bestbewerteten","bestbewertete","bestbewerteter","bestbewertetes","\u00fcberraschende","\u00fcberraschenden","\u00fcberraschendes","\u00fcberraschender","hilfreiche","hilfreiches","hilfreichen","hilfreicher","f\u00f6rdern","unterst\u00fctzen","helfen","spielerisch","spannende","spannendes","spannenden","spannender","gro\u00dfartige","gro\u00dfartiges","gro\u00dfartigen","gro\u00dfartiger","ideal","ideales","idealen","idealer","faszinierend","faszinierendes","faszinierenden","faszinierender","wichtig","wichtige","wichtiges","wichtigen","wichtiger","sicher","sichere","sicheres","sicheren","sicherer","umfassende","umfassendes","umfassenden","umfassender","ultimative","ultimatives","ultimativen","ultimativer","einzigartige","einzigartiges","einzigartigen","einzigartiger"],"diacritics":{"A":"[\\u0041\\u24B6\\uFF21\\u00C0\\u00C1\\u00C2\\u1EA6\\u1EA4\\u1EAA\\u1EA8\\u00C3\\u0100\\u0102\\u1EB0\\u1EAE\\u1EB4\\u1EB2\\u0226\\u01E0\\u01DE\\u1EA2\\u00C5\\u01FA\\u01CD\\u0200\\u0202\\u1EA0\\u1EAC\\u1EB6\\u1E00\\u0104\\u023A\\u2C6F]","AA":"[\\uA732]","AE":"[\\u00C6\\u01FC\\u01E2\\u00C4]","AO":"[\\uA734]","AU":"[\\uA736]","AV":"[\\uA738\\uA73A]","AY":"[\\uA73C]","B":"[\\u0042\\u24B7\\uFF22\\u1E02\\u1E04\\u1E06\\u0243\\u0182\\u0181]","C":"[\\u0043\\u24B8\\uFF23\\u0106\\u0108\\u010A\\u010C\\u00C7\\u1E08\\u0187\\u023B\\uA73E]","D":"[\\u0044\\u24B9\\uFF24\\u1E0A\\u010E\\u1E0C\\u1E10\\u1E12\\u1E0E\\u0110\\u018B\\u018A\\u0189\\uA779]","DZ":"[\\u01F1\\u01C4]","Dz":"[\\u01F2\\u01C5]","E":"[\\u0045\\u24BA\\uFF25\\u00C8\\u00C9\\u00CA\\u1EC0\\u1EBE\\u1EC4\\u1EC2\\u1EBC\\u0112\\u1E14\\u1E16\\u0114\\u0116\\u00CB\\u1EBA\\u011A\\u0204\\u0206\\u1EB8\\u1EC6\\u0228\\u1E1C\\u0118\\u1E18\\u1E1A\\u0190\\u018E]","F":"[\\u0046\\u24BB\\uFF26\\u1E1E\\u0191\\uA77B]","G":"[\\u0047\\u24BC\\uFF27\\u01F4\\u011C\\u1E20\\u011E\\u0120\\u01E6\\u0122\\u01E4\\u0193\\uA7A0\\uA77D\\uA77E]","H":"[\\u0048\\u24BD\\uFF28\\u0124\\u1E22\\u1E26\\u021E\\u1E24\\u1E28\\u1E2A\\u0126\\u2C67\\u2C75\\uA78D]","I":"[\\u0049\\u24BE\\uFF29\\u00CC\\u00CD\\u00CE\\u0128\\u012A\\u012C\\u0130\\u00CF\\u1E2E\\u1EC8\\u01CF\\u0208\\u020A\\u1ECA\\u012E\\u1E2C\\u0197]","J":"[\\u004A\\u24BF\\uFF2A\\u0134\\u0248]","K":"[\\u004B\\u24C0\\uFF2B\\u1E30\\u01E8\\u1E32\\u0136\\u1E34\\u0198\\u2C69\\uA740\\uA742\\uA744\\uA7A2]","L":"[\\u004C\\u24C1\\uFF2C\\u013F\\u0139\\u013D\\u1E36\\u1E38\\u013B\\u1E3C\\u1E3A\\u0141\\u023D\\u2C62\\u2C60\\uA748\\uA746\\uA780]","LJ":"[\\u01C7]","Lj":"[\\u01C8]","M":"[\\u004D\\u24C2\\uFF2D\\u1E3E\\u1E40\\u1E42\\u2C6E\\u019C]","N":"[\\u004E\\u24C3\\uFF2E\\u01F8\\u0143\\u00D1\\u1E44\\u0147\\u1E46\\u0145\\u1E4A\\u1E48\\u0220\\u019D\\uA790\\uA7A4]","NJ":"[\\u01CA]","Nj":"[\\u01CB]","O":"[\\u004F\\u24C4\\uFF2F\\u00D2\\u00D3\\u00D4\\u1ED2\\u1ED0\\u1ED6\\u1ED4\\u00D5\\u1E4C\\u022C\\u1E4E\\u014C\\u1E50\\u1E52\\u014E\\u022E\\u0230\\u022A\\u1ECE\\u0150\\u01D1\\u020C\\u020E\\u01A0\\u1EDC\\u1EDA\\u1EE0\\u1EDE\\u1EE2\\u1ECC\\u1ED8\\u01EA\\u01EC\\u00D8\\u01FE\\u0186\\u019F\\uA74A\\uA74C]","OE":"[\\u00D6]","OI":"[\\u01A2]","OO":"[\\uA74E]","OU":"[\\u0222]","P":"[\\u0050\\u24C5\\uFF30\\u1E54\\u1E56\\u01A4\\u2C63\\uA750\\uA752\\uA754]","Q":"[\\u0051\\u24C6\\uFF31\\uA756\\uA758\\u024A]","R":"[\\u0052\\u24C7\\uFF32\\u0154\\u1E58\\u0158\\u0210\\u0212\\u1E5A\\u1E5C\\u0156\\u1E5E\\u024C\\u2C64\\uA75A\\uA7A6\\uA782]","S":"[\\u0053\\u24C8\\uFF33\\u1E9E\\u015A\\u1E64\\u015C\\u1E60\\u0160\\u1E66\\u1E62\\u1E68\\u0218\\u015E\\u2C7E\\uA7A8\\uA784]","T":"[\\u0054\\u24C9\\uFF34\\u1E6A\\u0164\\u1E6C\\u021A\\u0162\\u1E70\\u1E6E\\u0166\\u01AC\\u01AE\\u023E\\uA786]","TZ":"[\\uA728]","U":"[\\u0055\\u24CA\\uFF35\\u00D9\\u00DA\\u00DB\\u0168\\u1E78\\u016A\\u1E7A\\u016C\\u01DB\\u01D7\\u01D5\\u01D9\\u1EE6\\u016E\\u0170\\u01D3\\u0214\\u0216\\u01AF\\u1EEA\\u1EE8\\u1EEE\\u1EEC\\u1EF0\\u1EE4\\u1E72\\u0172\\u1E76\\u1E74\\u0244]","UE":"[\\u00DC]","V":"[\\u0056\\u24CB\\uFF36\\u1E7C\\u1E7E\\u01B2\\uA75E\\u0245]","VY":"[\\uA760]","W":"[\\u0057\\u24CC\\uFF37\\u1E80\\u1E82\\u0174\\u1E86\\u1E84\\u1E88\\u2C72]","X":"[\\u0058\\u24CD\\uFF38\\u1E8A\\u1E8C]","Y":"[\\u0059\\u24CE\\uFF39\\u1EF2\\u00DD\\u0176\\u1EF8\\u0232\\u1E8E\\u0178\\u1EF6\\u1EF4\\u01B3\\u024E\\u1EFE]","Z":"[\\u005A\\u24CF\\uFF3A\\u0179\\u1E90\\u017B\\u017D\\u1E92\\u1E94\\u01B5\\u0224\\u2C7F\\u2C6B\\uA762]","a":"[\\u0061\\u24D0\\uFF41\\u1E9A\\u00E0\\u00E1\\u00E2\\u1EA7\\u1EA5\\u1EAB\\u1EA9\\u00E3\\u0101\\u0103\\u1EB1\\u1EAF\\u1EB5\\u1EB3\\u0227\\u01E1\\u01DF\\u1EA3\\u00E5\\u01FB\\u01CE\\u0201\\u0203\\u1EA1\\u1EAD\\u1EB7\\u1E01\\u0105\\u2C65\\u0250]","aa":"[\\uA733]","ae":"[\\u00E6\\u01FD\\u01E3\\u00E4]","ao":"[\\uA735]","au":"[\\uA737]","av":"[\\uA739\\uA73B]","ay":"[\\uA73D]","b":"[\\u0062\\u24D1\\uFF42\\u1E03\\u1E05\\u1E07\\u0180\\u0183\\u0253]","c":"[\\u0063\\u24D2\\uFF43\\u0107\\u0109\\u010B\\u010D\\u00E7\\u1E09\\u0188\\u023C\\uA73F\\u2184]","d":"[\\u0064\\u24D3\\uFF44\\u1E0B\\u010F\\u1E0D\\u1E11\\u1E13\\u1E0F\\u0111\\u018C\\u0256\\u0257\\uA77A]","dz":"[\\u01F3\\u01C6]","e":"[\\u0065\\u24D4\\uFF45\\u00E8\\u00E9\\u00EA\\u1EC1\\u1EBF\\u1EC5\\u1EC3\\u1EBD\\u0113\\u1E15\\u1E17\\u0115\\u0117\\u00EB\\u1EBB\\u011B\\u0205\\u0207\\u1EB9\\u1EC7\\u0229\\u1E1D\\u0119\\u1E19\\u1E1B\\u0247\\u025B\\u01DD]","f":"[\\u0066\\u24D5\\uFF46\\u1E1F\\u0192\\uA77C]","g":"[\\u0067\\u24D6\\uFF47\\u01F5\\u011D\\u1E21\\u011F\\u0121\\u01E7\\u0123\\u01E5\\u0260\\uA7A1\\u1D79\\uA77F]","h":"[\\u0068\\u24D7\\uFF48\\u0125\\u1E23\\u1E27\\u021F\\u1E25\\u1E29\\u1E2B\\u1E96\\u0127\\u2C68\\u2C76\\u0265]","hv":"[\\u0195]","i":"[\\u0069\\u24D8\\uFF49\\u00EC\\u00ED\\u00EE\\u0129\\u012B\\u012D\\u00EF\\u1E2F\\u1EC9\\u01D0\\u0209\\u020B\\u1ECB\\u012F\\u1E2D\\u0268\\u0131]","j":"[\\u006A\\u24D9\\uFF4A\\u0135\\u01F0\\u0249]","k":"[\\u006B\\u24DA\\uFF4B\\u1E31\\u01E9\\u1E33\\u0137\\u1E35\\u0199\\u2C6A\\uA741\\uA743\\uA745\\uA7A3]","l":"[\\u006C\\u24DB\\uFF4C\\u0140\\u013A\\u013E\\u1E37\\u1E39\\u013C\\u1E3D\\u1E3B\\u017F\\u0142\\u019A\\u026B\\u2C61\\uA749\\uA781\\uA747]","lj":"[\\u01C9]","m":"[\\u006D\\u24DC\\uFF4D\\u1E3F\\u1E41\\u1E43\\u0271\\u026F]","n":"[\\u006E\\u24DD\\uFF4E\\u01F9\\u0144\\u00F1\\u1E45\\u0148\\u1E47\\u0146\\u1E4B\\u1E49\\u019E\\u0272\\u0149\\uA791\\uA7A5]","nj":"[\\u01CC]","o":"[\\u006F\\u24DE\\uFF4F\\u00F2\\u00F3\\u00F4\\u1ED3\\u1ED1\\u1ED7\\u1ED5\\u00F5\\u1E4D\\u022D\\u1E4F\\u014D\\u1E51\\u1E53\\u014F\\u022F\\u0231\\u022B\\u1ECF\\u0151\\u01D2\\u020D\\u020F\\u01A1\\u1EDD\\u1EDB\\u1EE1\\u1EDF\\u1EE3\\u1ECD\\u1ED9\\u01EB\\u01ED\\u00F8\\u01FF\\u0254\\uA74B\\uA74D\\u0275]","oe":"[\\u00f6]","oi":"[\\u01A3]","ou":"[\\u0223]","oo":"[\\uA74F]","p":"[\\u0070\\u24DF\\uFF50\\u1E55\\u1E57\\u01A5\\u1D7D\\uA751\\uA753\\uA755]","q":"[\\u0071\\u24E0\\uFF51\\u024B\\uA757\\uA759]","r":"[\\u0072\\u24E1\\uFF52\\u0155\\u1E59\\u0159\\u0211\\u0213\\u1E5B\\u1E5D\\u0157\\u1E5F\\u024D\\u027D\\uA75B\\uA7A7\\uA783]","s":"[\\u0073\\u24E2\\uFF53\\u015B\\u1E65\\u015D\\u1E61\\u0161\\u1E67\\u1E63\\u1E69\\u0219\\u015F\\u023F\\uA7A9\\uA785\\u1E9B]","ss":"[\\u00DF]","t":"[\\u0074\\u24E3\\uFF54\\u1E6B\\u1E97\\u0165\\u1E6D\\u021B\\u0163\\u1E71\\u1E6F\\u0167\\u01AD\\u0288\\u2C66\\uA787]","tz":"[\\uA729]","u":"[\\u0075\\u24E4\\uFF55\\u00F9\\u00FA\\u00FB\\u0169\\u1E79\\u016B\\u1E7B\\u016D\\u01DC\\u01D8\\u01D6\\u01DA\\u1EE7\\u016F\\u0171\\u01D4\\u0215\\u0217\\u01B0\\u1EEB\\u1EE9\\u1EEF\\u1EED\\u1EF1\\u1EE5\\u1E73\\u0173\\u1E77\\u1E75\\u0289]","ue":"[\\u00FC]","v":"[\\u0076\\u24E5\\uFF56\\u1E7D\\u1E7F\\u028B\\uA75F\\u028C]","vy":"[\\uA761]","w":"[\\u0077\\u24E6\\uFF57\\u1E81\\u1E83\\u0175\\u1E87\\u1E85\\u1E98\\u1E89\\u2C73]","x":"[\\u0078\\u24E7\\uFF58\\u1E8B\\u1E8D]","y":"[\\u0079\\u24E8\\uFF59\\u1EF3\\u00FD\\u0177\\u1EF9\\u0233\\u1E8F\\u00FF\\u1EF7\\u1E99\\u1EF5\\u01B4\\u024F\\u1EFF]","z":"[\\u007A\\u24E9\\uFF5A\\u017A\\u1E91\\u017C\\u017E\\u1E93\\u1E95\\u01B6\\u0225\\u0240\\u2C6C\\uA763]"},"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasRedirection":true,"hasBreadcrumb":true},"homeUrl":"https:\/\/medicalpointinternational.com\/de\/","objectID":15243,"objectType":"post","locale":"de","localeFull":"de_DE","overlayImages":{"play":{"name":"Wiedergabezeichen","url":"https:\/\/medicalpointinternational.com\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","path":"\/home\/medicalpointint\/public_html\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-play.png","position":"middle_center"},"gif":{"name":"GIF-Symbol","url":"https:\/\/medicalpointinternational.com\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","path":"\/home\/medicalpointint\/public_html\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/icon-gif.png","position":"middle_center"}},"defautOgImage":"https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2024\/12\/Medical-Point-International-Hospital-Empty-Pic.png","customPermalinks":true,"isUserRegistered":true,"autoSuggestKeywords":true,"connectSiteUrl":"https:\/\/rankmath.com\/auth?site=https%3A%2F%2Fmedicalpointinternational.com%2Fde%2F&r=https%3A%2F%2Fmedicalpointinternational.com%2Fde%2Fwp-json%2Fwp%2Fv2%2Fpages%2F15243%3Fnonce%3Dcf35bb0c81&pro=1","maxTags":100,"trendsIcon":"<svg viewBox=\"0 0 610 610\"><path d=\"M18.85,446,174.32,290.48l58.08,58.08L76.93,504a14.54,14.54,0,0,1-20.55,0L18.83,466.48a14.54,14.54,0,0,1,0-20.55Z\" style=\"fill:#4285f4\"\/><path d=\"M242.65,242.66,377.59,377.6l-47.75,47.75a14.54,14.54,0,0,1-20.55,0L174.37,290.43l47.75-47.75A14.52,14.52,0,0,1,242.65,242.66Z\" style=\"fill:#ea4335\"\/><polygon points=\"319.53 319.53 479.26 159.8 537.34 217.88 377.61 377.62 319.53 319.53\" style=\"fill:#fabb05\"\/><path d=\"M594.26,262.73V118.61h0a16.94,16.94,0,0,0-16.94-16.94H433.2a16.94,16.94,0,0,0-12,28.92L565.34,274.71h0a16.94,16.94,0,0,0,28.92-12Z\" style=\"fill:#34a853\"\/><rect width=\"610\" height=\"610\" style=\"fill:none\"\/><\/svg>","showScore":true,"siteFavIcon":"https:\/\/medicalpointinternational.com\/wp-content\/uploads\/2024\/12\/Medical-Point-International-Hospital-Empty-Pic-150x150.png","canUser":{"general":false,"advanced":false,"snippet":false,"social":false,"analysis":false,"analytics":false,"content_ai":false},"showKeywordIntent":true,"isPro":true,"is_front_page":false,"trendsUpgradeLink":"https:\/\/rankmath.com\/pricing\/?utm_source=Plugin&utm_medium=CE%20General%20Tab%20Trends&utm_campaign=WP","trendsUpgradeLabel":"Upgraden","trendsPreviewImage":"https:\/\/medicalpointinternational.com\/wp-content\/plugins\/seo-by-rank-math\/assets\/admin\/img\/trends-preview.jpg","currentEditor":false,"homepageData":{"assessor":{"powerWords":["abgelenkt","abgesturzt","absolut","abstossend","aburd","abweisen","adaquat","aggressiv","ahnungslos","akkurat","alarmierend","alarmiert","albtraum","all-inclusive","allererste","allererster","allererstes","alleswisser","am schlechtesten","am wichtigsten","angewidert","angriff","angsteinflossend","angstlich","animiert","ankundigung","anonym","anpassbar","anspruchslos","anstossig","antagonistisch","apokalypse","applaus","argumentativ","arm","armageddon","arrogant","atemberaubend","attacke","attraktiv","aufdeckend","aufgebracht","aufgedeckt","aufgeregt","aufheiternd","aufregend","aufregende","aufregenden","aufregung","aufstachelnd","aufstandisch","aufsteigend","auftreibend","augenoffnend","ausgelassen","ausgeruht","ausgespielt","ausgewahlt","ausgewuhlt","ausnutzen","aussergewohnlich","autark","authentisch","autoritat","backdoor","badass","beangstigend","bedenklich","bedingungslos","bedrohen","bedroht","beforderung","befreit","befriedigend","befriedigt","begehren","begeistern","begeistert","begeisterung","beherzt","behind the scenes","beichte","beleidigung","belohnung","bemerkenswert","beneiden","bequem","beruhmt","beschadigen","beschamend","beschmutzt","beschuldigen","beschutzen","besitz","bessesen","bestatigen","bestatigt","beste","bestimmt","bestrafen","betrug","betrugen","bewahrt","bewiesen","bewiesenermassen","bewusst","bezahlbar","bezaubernd","bizarre","bleich","blendend","blut","blutbad","blutig","bombe","bonanza","bonus","bosartig","bose","boshaft","brilliant","brodelnd","brutal","budget","bullshit","bully","bunt","bunte","bunten","case study","cash","challenge","challgene","chaos","cheat-sheet","clever","content","cool","courage","dankbar","daruber redet keiner","deadline","definitiv","dekadent","demoralisierend","demut","desillusioniert","detailiert","diagnose","die wahrheit","direkt","disastros","discount","dokument","dollar","dominieren","doppelt","download","dreckig","dreifach","dreistigkeit","dringend","dringlichkeit","dumm","dummkopf","dummlich","durchbruch","duselig","dynamik","echt","effektiv","effizient","ehrlich","eier","eifersuchtig","eifrig","eindeutig","eindrucksvoll","eine stufe besser","einfach","einfachheit","einfallsreich","eingebildet","eingeschrankt","eingesperrt","einmalig","einsam","eintauchen","einzigartig","eisern","eliminieren","elite","empathie","empfehle","empfehlen","endeffekt","energie","energisch","enorm","entdecken","entfesselt","entfremdet","enthullen","enthullung","enthusiastisch","entmachtet","entsetzlich","entspannt","entzuckend","entzunden","epidemisch","episch","erbarmlich","erfolg","erfolgreich","erfolgsbilanz","erfreut","erfullen","erfullt","ergebnisse","ergreifen","erhaben","erheben","erhohen","erledigt","ermachtigt","ermudet","ernmutigt","ernsthaft","erobern","erroten","errungenschaft","erschaffen","erschrocken","ersehnen","ersparnisse","erstattbar","erstatten","erstaunlich","erste","ertrinken","essentiell","ethisch","euphorisch","exakt","exklusiv","exklusivitat","exkuisit","experte","explodieren","explosiv","exposed","extrem","exzellent","fahig","fahigkeiten","fail","falle","fantasie","fantastischen","farbenfroh","farbenfrohe","faszinierend","faszinierende","faul","faux pas","faux","fehler","feindselig","feldstudie","fesselnd","festlich","festmahl","festplatte","final","flirt","fluchtling","flussig","fokus","fokussiert","folter","formel","frech","freebie","frei","freiheit","freudig","friedlich","frohlich","frohlichkeit","frustriert","fundamental","fur immer","furchtbar","furchtlos","gangster","garantiert","geblendet","geehrt","gefahr","gefahrlich","gefangen","gefangnis","gefeuert","gegensatzlich","gehassig","geheimnis","geheimnisse","geil","geisseln","geist","geistesgestort","gelassen","geld zuruck","geld","genial","gepackt","gerade angekommen","gerissen","geschenk","geschmuggelt","geschutzt","gestandnis","gestandnisse","gestopft","gestresst","gesucht","gesund","getauscht","getestet","getotet","gewaltig","gewalttatig","gewidmet","gewinnspiel","gier","gierig","gift","giftig","gigantisch","giveaway","glamourose","glanzend","glaube","glaubwurdig","gleichmassig","glittering","glitzernde","gluckselig","golden","grandios","grandiose","grandiosen","grandioses","grauenhaft","grausamkeit","grinsen","groesste","gross","grossartig","grossartig","grossartige","grossartigen","grossartiger","grossartiges","grosse","grossen","grosste","grosszugig","grotesk","grube","grundlegend","gruselig","gunstig","hack","hamisch","hammer","handelsgeheimnis","hartnackig","hass","heilig","heimlich","heisshunger","heisshungrig","heiter","held","hell","herablassend","herausfordernd","herausforderung","herausvorderung","herrlichen","herrschend","hervorragend","herz","herzbrechend","herzerwahrmend","heute","hightech","hilflosigkeit","hilfreich","hilfsbereit","himmlisch","hinterhaltig","hoax","hocheffektiv","hochnasig","hochste","hoffnung","hoffnungsvoll","holle","holocaust","horror","how to","humor","hungrige","hurrikan","hypnotisch","hypnotisierend","idiot","idiotisch","illegal","immer","informativ","inhalt","inkompetent","innovativ","insider","inspirierend","inspiriert","intelligent","intensiv","interessant","interessante","invasion","investment","ist da","jackpot","jederzeit kundigen","jetzt","jubilant","jumpstart","jung","kadaver","kampf","katapult","katastrophe","kaufen","kein risiko","keine verpflichtung","kickstart","kindisch","kitschig","klaglich","klar","knast","kollabieren","kollosal","komfortabel","komisch","kompetitiv","komplett","kompromiss","komsich","konstruktiv","kontrollierend","kontrollverlust","kooperativ","kopie","korrupt","kostenlos","kraftlos","kraftvoll","krankhaft","kreativ","kreative","kriese","kritisch","kruppel","lachen","lacherlich","lahm","last minute","lauernd","lebendig","lebenslanglich","lecken","lecker","legendar","legitim","leiche","leicht","leiden","leider","leise","letzte chance","letzte","leuchtend","liberal","licht","liebe","liebenswurdig","liebevoll","life-changing","limitiert","lohnend","loser","losung","lugen","lugend","lukrativ","lust","lustig","lustige","lustigsten","luxorios","magisch","mainstream","mammut","manipulativ","massiv","masterclass","meditierend","meiseter","meistverkauft","meltdown","millionen","mind-blowing","minderwertig","minimalist","missbrauch","misstrauisch","mittelmassig","mittig","modern","moderne","moglichkeiten","monetarisieren","monumental","mord","motiviert","muhelos","muhevoll","mull","mut","mutig","nachmachen","nachteile","nackt","nagel","naiv","natural","nazi","neid","nervos","neu","niedertrachtig","niemals","notfall","notiert","nutzlich","nutzlos","offensichtlich","offiziel","offnen","ohne hintergedanken","ok","okay","okonomisch","on-demand","opfer","optimistisch","overnight","packend","panik","panzer","paralisiert","pas","passioniert","pause","payback","peinlich","perfekt","perplex","perskeptive","pessimistisch","pfund","piranha","pleite","plotzlich","pochend","polarisierend","popular","portfolio","praktisch","preis","prestige","privat","privatsphare","priviligiert","problem","produktiv","professionell","profit","profitabel","provokativ","provozierend","prozess","psychologisch","qual","qualen","qualitat","rabatt","rache","rachsuchtig","raffiniert","rasend","rat","rau","recherche","reduziert","reflektieren","regeln","reich","reiche","reichtum","relaxed","report","responsive","revolutionar","riesig","risiko","riskant","riskieren","rotzfrech","rowdy","ruckrat","ruckschlag","rucksichtlos","ruhig","ruiniert","sabotiert","sadistisch","sale","sarkastisch","scam","schabig","schadigend","schadlich","schamlos","schatz","schicksal","schlachten","schlafen","schlag","schlau","schlimm","schmerzhaft","schmerzlos","schmuggel","schnell","schnellstart","schokierend","schonheit","schrecklich","schreien","schritt fur schritt","schuld","schuldlos","schwach","schwarm","schwarzmarkt","schwerkraft","schwinden","sechsstellig","sehenswerte","selbsthass","selten","sensationell","sex","sexy","sicher","sicherheit","sicherlich","sieg","sill","simpel","sinnlich","sinnlos","skandal","skandalos","skill","sklave","sneak-peek","snob","sofort gespart","sofort","sollte","sonnig","sonnige","sonnigen","sorgen","sorgfaltig","sorglos","spannend","sparen","sparsam","spass","spassig","spektakular","speziell","spielen","spoiler","spontan","spotlight","stabil","stark","start","stoisch","stolz","stop","strahlend","strangulieren","strategie","studien","stumperhaft","stur","sunden","sundigend","super","superb","survival","tapfer","tauschend","teaser","technologie","terror","terrorist","teuer","tief","tiefgreifend","tierisch","tod","todlich","toll","tolle","toller","tortur","tot","tote","toten","totend","toxisch","tragisch","tragodie","transfomieren","transparenz","trauma","traumatisiert","traurigkeit","trend","tricks","trigger","triumpf","trocken","trotz","trugerisch","tweaks","tyrann","ubel","uberfordert","uberkommen","uberleben","uberlegen","uberraschend","uberrascht","uberraschung","uberwaltigend","uberwinden","ultimativ","umfassend","umstritten","umwerfend","unatorisiert","unaufhaltbar","unausgelasted","unbedacht","unbeliebt","unbeschwert","unbewusst","undercover","undokumentiert","unehrlich","unentschlossen","unerwartet","unfahig","ungeduldig","ungedult","ungehort","ungemutlich","ungerechtfertigt","ungesehen","ungetrubt","ungewohnlich","ungezogen","unglaublich","unglaubliches","uninteressiert","unkontrollierbar","unkonventionell","unlimitiert","unpenetrierbar","unschuldig","unsicher","unstabil","unter verschluss","untergrund","unterhaltsam","unterstutz","unterstutzend","unubertroffen","unvergesslich","unverneinbar","unvoreingenommen","unwiderstehlich","unwirtlich","unzensiert","unzuverlassig","up-selling","vaporisieren","verangstigt","verantwortlich","verargert","verarscht","verbessert","verbluffend","verblufft","verboten","verbreiten","verdachtig","verdammt","verdeckt","vereinfacht","verfuhrend","vergebend","vergessen","vergleich","verhauen","verifizieren","verkommen","verlegen","verletzbar","verletzt","verlockend","verloren","vermasselt","vermeiden","vermogen","vernichten","vernichtend","vernunftig","veroffentlichung","verpassen","verraterisch","verruckt","versagen","verschwitzt","versichert","verspielt","versprechend","versteckt","vertrauenswurdig","vertraulich","vertraumt","verurteilend","verwunderlich","verwundet","verzaubernd","verzweifelt","vierfach","vogelfrei","vollig","vollstandig","vorsicht","vorstellungskraft","vorteil","wachstum","wagemutig","wahnsinn","wahnsinnig","wahrhaftig","wahrheit","wahrheitsgemass","wahrscheinlich","warnung","was dir keiner sagt","wehleidig","welt","wenig bekannt","wert","wertvoll","wichtig","widerlich","wiedererkannt","wild","wilde","wilden","willensstarke","wirr","wohltatigkeit","wortlich","wunder","wunderbar","wunderbaren","wunderschon","wutend","zeichen","zeitig","zen","zensiert","zerschlagen","zerschmetternd","zerstorend","zertifiziert","zielorientiert","zischend","zischt","zocken","zogernd","zugeben","zuruckgehalten","zuruckgelassen","zuruckweisen","zusatzlich","zutaten","zuverlassig","zwangsernahrt","zweifelnd","zwickend","zwingend","einfache","einfachen","einfaches","einfacher","simple","simplen","simples","simpler","besten","bestes","bester","beste","bestbewertet","bestbewerteten","bestbewertete","bestbewerteter","bestbewertetes","\u00fcberraschende","\u00fcberraschenden","\u00fcberraschendes","\u00fcberraschender","hilfreiche","hilfreiches","hilfreichen","hilfreicher","f\u00f6rdern","unterst\u00fctzen","helfen","spielerisch","spannende","spannendes","spannenden","spannender","gro\u00dfartige","gro\u00dfartiges","gro\u00dfartigen","gro\u00dfartiger","ideal","ideales","idealen","idealer","faszinierend","faszinierendes","faszinierenden","faszinierender","wichtig","wichtige","wichtiges","wichtigen","wichtiger","sicher","sichere","sicheres","sicheren","sicherer","umfassende","umfassendes","umfassenden","umfassender","ultimative","ultimatives","ultimativen","ultimativer","einzigartige","einzigartiges","einzigartigen","einzigartiger"],"diacritics":true,"researchesTests":["contentHasTOC","contentHasShortParagraphs","contentHasAssets","keywordInTitle","keywordInMetaDescription","keywordInPermalink","keywordIn10Percent","keywordInContent","keywordInSubheadings","keywordInImageAlt","keywordDensity","keywordNotUsed","lengthContent","lengthPermalink","linksHasInternal","linksHasExternals","linksNotAllExternals","titleStartWithKeyword","titleSentiment","titleHasPowerWords","titleHasNumber","hasContentAI"],"hasBreadcrumb":true,"serpData":{"title":"%sitename% %page% %sep% %sitedesc%","description":"","titleTemplate":"%sitename% %page% %sep% %sitedesc%","descriptionTemplate":"","focusKeywords":"","breadcrumbTitle":"Startseite","robots":{"index":true},"advancedRobots":{"max-snippet":"-1","max-video-preview":"-1","max-image-preview":"large"},"facebookTitle":"","facebookDescription":"","facebookImage":"","facebookImageID":""}}},"isAnalyticsConnected":false,"tocTitle":"Table of Contents","tocExcludeHeadings":[],"listStyle":"ul"},"_links":{"self":[{"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/15243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/comments?post=15243"}],"version-history":[{"count":15,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/15243\/revisions"}],"predecessor-version":[{"id":76866,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/15243\/revisions\/76866"}],"up":[{"embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/pages\/14366"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/media\/11007"}],"wp:attachment":[{"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/media?parent=15243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/categories?post=15243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalpointinternational.com\/de\/wp-json\/wp\/v2\/tags?post=15243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}